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1. Introduction 
The experience of pain is complex, multifaceted, and “an unpleasant sensory and emotional 
experience,” as defined in part by the International Association for the Study of Pain.  It is a 
personal, subjective experience that involves sensory, emotional and behavioral factors 
associated with actual or potential tissue injury (Rawal). The differential behavior response 
to surgical incision can be influenced by many variables including global (i.e., personality, 
gender, age, cultural background, pre-existing pain syndromes, genetic makeup, kind and 
type of surgical approach, cultural background) and specific (i.e., fear, anxiety, depression, 
anger, and coping) psychological factors (Eccleston, 2001). Only by considering all 
concomitant factors can physicians provide optimal treatment. 
Millions of surgeries are performed on an annual basis, necessitating the frequent use of 
acute postoperative pain management. There are many types of surgery and, with few 
exceptions, all are painful. Fear of uncontrolled pain is among the primary concerns of many 
patients who are about to undergo surgery. 
One of the most important factors in determining when a patient can be safely discharged 
from a surgical facility, and that also has a major influence on the patient’s ability to resume 
his/her normal activities of daily living, is the adequacy of postoperative pain control. Pain 
is a predictable part of the postoperative experience. Unrelieved postoperative pain may 
result in clinical and psychological changes that increase morbidity and mortality as well as 
costs and that decrease quality of life (Carr& Goudas, 1999). 
The guidelines for acute pain management in the perioperative setting published in 1992 
and 1995 (Acute Pain, 1992; American Pain, 1995; Practice Guidelines, 1995) promoted 
aggressive treatment of acute pain and educate patients about the need to communicate 
unrelieved pain. Nonetheless these guidelines appear to have had little influence on practice 
patterns or on improved pain control for patients. In a study of Warfield and Kahn 
(Warfield&Kahn, 1995) they found three of four patients reported experiencing pain after 
surgery, and 80% of these patients rated pain after surgery as moderate to extreme.  Since 
their study, newer drugs,  techniques and protocols for postoperative pain management 
have been developed, and minimally invasive surgical techniques, such as endoscopic 
procedures, are used more frequently. These changes in practice patterns thought that they 
could affect the management of postoperative pain and patient attitudes about pain. But in a 
recent study (Apfelbaum, 2003) that assessed patients’ postoperative pain experience and 
www.intechopen.com
 
Pain Management – Current Issues and Opinions 
 
178 
the status of acute pain management in a random sample, approximately 80 percent of 
patients said (not very different the previous study mentioned above) they experienced 
acute pain after surgery. The authors concluded that; despite an increased focus on pain 
management programs and the development of new standards for pain management, many 
patients continue to experience intense pain after surgery.   
Effective and appropriate pain management requires a proactive approach using a variety of 
treatment modalities to obtain an optimal outcome with respect to facilitating rapid 
recovery and returning to full function, allowing early discharge from hospital, improving 
quality of life for the patient and reducing morbidity (Rawal).   Protocols for postoperative 
pain treatment should be made with considering patients’ needs, surgical indications, and 
institutional resources. It is important to use effective state-of-the-art techniques combined 
with hospital protocols for early rehabilitation and recovery. 
Many options are available for the treatment of postoperative pain, including systemic (i.e., 
opioid and nonopioid) analgesics and regional (i.e., neuraxial and peripheral) analgesic 
techniques. Multimodal analgesia is achieved by combining different analgesics that act by 
different mechanisms and at different sites in the nervous system, resulting in additive or 
synergistic analgesia with lowered adverse effects of sole administration of individual 
analgesics (Kehlet&Dahl, 1993). It also refers to concurrent application of analgesic 
pharmacotherapy in combination with regional analgesia (Elvir Lazo&White, 2010). 
This chapter’s aim is to overview on the topic of multimodal analgesia for postoperative 
pain management and to provide an update on the drugs and techniques used for this 
approach. 
2. Consequences of postoperative pain 
When an appropriate analgesic treatment is not given for postoperative pain, various 
adverse effects might occur in the respiratory, cardiovascular, gastrointestinal, urinary, 
endocrinological systems, as well as in patient's metabolisms and mentality. These changes 
were relievable with application of appropriate types of analgesic regimens.   
Postoperative pain, especially when poorly controlled, may produce a range of detrimental 
acute (i.e., adverse physiologic responses) (Vadivelu et al, 2010) and chronic effects (i.e., 
delayed long-term recovery and chronic pain) (Perkins&Kehlet, 2000). Good pain control 
after surgery is important to prevent negative outcomes such as tachycardia, hypertension, 
myocardial ischemia, decrease in alveolar ventilation, immobility, deep venous thrombosis 
and poor wound healing (Vadivelu et al, 2010; Nett, 2010).  
Pathophysiology of acute pain, includes of changes in neuroendocrine, respiratory and renal 
function, gastrointestinal activity, circulatory and autonomic nervous system activity.  
Unsufficient pain management can cause acute and chronic effects: 
2.1 Acute effects 
 Emotional and physical suffering for the patient 
 Sleep disturbance (with negative impact on mood and mobilisation) 
 Respiratory system side effects (leading to atelectasis, retention of secretions and 
pneumonia) 
 Decreased respiratory motion 
 Inhibition of cough and sputum excretion 
 Cardiovascular side effects (such as hypertension and arrhythmias) 
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 Increased oxygen consumption (with negative impact in the case of coronary artery 
disease, leading to coronary ischemia and myocardial infarction) 
 Impaired gastrointestinal motility (while opioids induce constipation or nausea, 
untreated pain may also be an important cause of impaired bowel movement or 
postoperative nausea and vomiting-PONV) 
 Delays mobilisation and promotes thromboembolism (postoperative pain is one of the 
major causes for delayed mobilisation) 
 Increased sympathetic activity 
 increased release of catecholamines (resulting increase in systemic vascular 
resistance, cardiac work and myocardial oxygen consumption associated negative 
effects in patients with coronary artery diseases) 
 reduced blood flow in lower extremities (resulting a higher risk of deep vein 
thrombosis) 
2.2 Chronic effects 
 Severe acute pain is a risk factor for the development of chronic pain 
 Sleep disturbance (with negative impact on mood and mobilisation) 
 Risk of behavioural changes (frequently in children for a prolonged period after 
surgical pain) 
 Poor wound healing  
 Delay in long-term recovery 
Chronic pain is a potential adverse outcome from surgery. It is costly to society in terms of 
suffering and disability. For humanitarian and economic reasons, the problem of chronic 
pain after surgery should be addressed. In a review of Perkins et al. (Perkins&Kehlet, 2000) 
they showed there was a significant variability in the incidence of chronic pain among 
surgical procedures (i.e. 3-56% for cholecystectomy, 0-37% for inguinal hernia surgery, 11-
57% for breast surgery).  They concluded that chronic pain after surgery was common as 
that has been confirmed with another review (Camann, 1998). Another conclusion of this 
study is; the intensity of acute postoperative pain was one of the most striking predictive 
factor for chronic pain, especially following breast surgery (Elia, 2005), thorasic surgery 
(Carli F,2002; Viscusi, 2004) and hernia repair (Birnbach, 1989). 
3. Multimodal approach to postoperative pain 
Advances in the knowledge of molecular mechanisms have led to the development of 
multimodal analgesia and new pharmaceutical products to treat postoperative pain.  
Postoperative pain treatment may not be enough to provide major improvements in some 
outcomes because it is unlikely that a unimodal intervention can be effective in 
addressing a complex problem such as perioperative outcomes (Boisseau, 2001; 
Kehlet&Nolte, 2001). The analgesic benefits of controlling postoperative pain are 
generally maximized when a multimodal strategy to facilitate the patient's convalescence 
is implemented (Kehlet, 1997). Pain involves multiple mechanisms that ideally require 
treatment using a multimodal (or ‘balanced’) analgesic technique (White&Kehlet, 2010) 
Principles of a multimodal strategy include control of postoperative pain to allow early 
mobilization, early enteral nutrition, education, and attenuation of the perioperative stress 
response through the use of regional anesthetic techniques and a combination of analgesic 
agents (i.e., multimodal analgesia).   
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The concept of multimodal analgesia was introduced more than a decade ago as  
a technique to improve analgesia and reduce the incidence of opioid-related adverse 
events. Multimodal analgesia is achieved by combining different analgesics that act  
by different mechanisms at different sites in the nervous system, reducing the incidence  
of side effects owing to the lower doses of the individual drugs (Buvanendran&Kroin 
2009). For example, epidural opioids can be administered in combination with epidural 
local anesthetics; intravenous opioids can be administered in combination with 
Nonsteroidal Antiinflammatory Drug (NSAID)s, which have a dose sparing effect  
for systemically administered opioids. It also refers to concurrent application of analgesic 
pharmacotherapy in combination with regional analgesia (Elvir Lazo&White, 2010; 
Rawal).  
In the literature some different definitions of multimodal analgesia exists. In some contexts, 
multimodal analgesia refers to systemic administration of analgesic drugs with different 
mechanisms of action, whereas in other situations it refers to concurrent application of 
analgesic pharmacotherapy in combination with regional analgesia. Multimodal analgesia is 
based on to choice paracetamol and NSAIDs for low intensity pain with opioid analgesics 
and/or local analgesia techniques being used for moderate and high intensity pain as 
indicated.  (Elvir Lazo&White, 2010; Rawal) (Table 1) 
 
 
Mild intensity pain Moderate intensity pain Severe intensity pain 
For example: 
Inguinal hernia 
Varices 
Laparoscopy 
For example: 
Hip replacement 
Hysterectomy 
Jaw surgery 
For example: 
Thoracotomy 
Upper abdominal surgery 
Aortic surgery 
Knee replacement 
(i) Paracetamol and wound 
infiltration with local anesthetic 
(ii) NSAIDs (unless 
contraindicated) and 
(iii) Epidural local analgesia or 
major peripheral nerve or 
plexus block or opioid injection 
(IV PCA) 
(i) Paracetamol and wound infiltration with local anesthetic 
(ii) NSAIDs (unless contraindicated) and 
(iii) Peripheral nerve block 
(single shot or continuous infusion) or opioid injection (IV 
PCA) 
(i) Paracetamol and wound infiltration with local anesthetic 
(ii) NSAIDs (unless contraindicated) and 
(iii) Regional block analgesia 
Add weak opioid or rescue analgesia with small increments of intravenous strong opioid 
if necessary 
Table 1. Treatment options in relation to magnitude of postoperative pain expected 
following different types of surgery (by permission from Publisher AstraZeneca) 
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A lower incidence of adverse effects and improved analgesia has been demonstrated with 
multimodal analgesia techniques, which may provide for shorter hospitalization times, 
improved recovery and function, and possibly decreased healthcare costs (Buvanendran & 
Kroin, 2009). 
To achieve a maximum short-term and long-term benefits from multimodal analgesic 
therapies, the pain management would be initiated as a preventive in the preoperative 
period continued in the early postoperative period  and  extended into  the  postcharge 
period for  3-7 days (Bisgaard, 2006; White et al, 2007). A deficiency in the design of many 
of the published studies involving multimodal analgesic therapies is that the drug 
regimens were not continued into the postdischarge period (Ma, 2004). For example, only 
immediate pre- and postoperative administration of the cyclooxygenase 2 (COX-2) 
inhibitor rofecoxib as part of a multimodal analgesic regimen in outpatients undergoing 
inguinal hernia repair provided limited benefits beyond the early postoperative period 
(White&Kehlet, 2007). However, when the COX-2 inhibitors are administered for 3 to 5 
days after ambulatory surgery, (Gan, 2004;  Joshi, 2004) the greater benefits were achieved 
with respect to clinically relevant patient outcomes (eg, resumption of normal activities) 
and improvements in pain control. Bisgaard et al (Bisgaard, 2006) concluded that a 
multimodal analgesic regimen consisting of a preoperative single dose of dexamethasone, 
incisional local anesthetics (at the beginning and/or end of surgery), and continuous 
treatment with NSAIDs (or COX-2 inhibitors) during the first 3 to 4 days provided the 
best clinical outcome. Moreover, recent clinical studies suggest that when classical 
NSAIDs or more selective COX-2 inhibiting drugs were administered for 3–5 days after 
ambulatory surgery, a significant benefit was achieved with respect to clinically relevant 
patient outcomes (e.g., resumption of normal activities) and improvements in short-term 
pain control (Gan, 2004; White, 2007). 
A multimodal analgesic regimen should be adjusted to meet the needs of the individual 
patient by taking into consideration their pre-existing medical conditions, types of 
surgery, and previous experiences related to both acute and chronic pain management. 
Critical multimodal protocols must be designed based on surgical procedures and 
structural organization to warrant improved outcome including having minimum side 
effects related to the treatment and rapid returning to social life and daily activities 
(Fanelli, 2008). 
Several multimodal approaches have been advocated based on different combinations of 
anti-inflammatory drugs, and regional anesthesia (epidural, peripheral nerve blocks, 
paravertebral blocks, and local injection/infusion of local anesthetics) (Buvanendran, 2010; 
Mathiesen, 2009). Although each of these drugs and/or techniques has been demonstrated 
as being effective in reducing the need for postoperative intravenous opioids alone, the 
evidence supporting specific combinations of drugs and/or regional techniques is still 
limited. 
3.1 Multidisciplinary approach 
Faster recovery, reduced hospital stay, and decreased length of convalescence can occur if 
multimodal analgesia is combined with a rehabilitation program that is multidisciplinary 
and multimodal (Gajraj&Joshi, 2005).  
Treatment of postoperative pain requires good multi-disciplinary and multi-professional co-
operation. Multidisciplinary team consists of the anesthesiologist himself has overall 
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responsibility, pain nurse and specialist surgeon, sometimes pharmacist. In the ward the 
patient’s physician and nurse, physiotherapist when needed are responsible for all care, in 
partnership with the pain team. The nurse is responsible to report the patient’s  intensity of 
pain to the physician and to treat the pain within the defined rules of the local guidelines. 
Also should pay attention to the effects and side effects of the pain treatment. The pain team 
nurse is the first point of contact while the anesthesiologist and pharmacist are available to 
provide specialist advice (Rawal).  
All staff involved in the treatment of postoperative pain require regularly updated training 
emphasising the importance of team-working and co-operation. In this training programme 
the main headings should be included as; a. Physiology and pathophysiology of pain, b. 
Pharmacology of analgesics, c. Locally available treatment methods d. Monitoring routines 
with regard to treatment of pain and e. Local document for treatment and assessment of pain 
(Rawal). 
It is important to understand of the postoperative pain experience from a patient’s 
perspective, if health care professionals are to identify ways to improve care. In Apfelbaum 
et al study (Apfelbaum et al, 2003); when asked about attitudes regarding pain and pain 
medications, 75% of patients believed that it was necessary to experience some pain after 
surgery, and 8% of patients had postponed surgery because they were worried about the 
possibility of experiencing pain. Although most patients claimed to receive preoperative 
education on postoperative pain management, that study’s findings suggested that a 
patient’s real concern is not adequately addressed. 
The patient himself and family members are also to be undertaken as the members of the 
multidisciplinary team. Education is an important role in this point. Patients are unlikely to 
be aware of postoperative pain treatment techniques and as the success of pain relief is 
influenced by their knowledge and beliefs, it is helpful to give patients (and parents in case 
of cognitively impaired, severely emotionally disturbed, children) detailed information 
about postoperative pain and pain treatment. Adequate information gives the patient 
realistic expectations of the care that can be provided (pain relief, not a "pain free status"). 
Patients who do not speak the local language, and patients whose level of education or 
cultural background differs significantly from that of their health care team need special 
concern. A preoperative discussion with the patient and relatives can be helpful about an 
effective postoperative pain management (Rawal). 
It is important to emphasize the need for collaboration between the various health care 
providers involved in the patient’s perioperative care (eg, anesthesiologists, surgeons, 
nurses, and physiotherapists) to integrate improved perioperative pain management 
strategies with the recently described fast-track recovery paradigms (White, 2007). This type 
of multi-disciplinary approach has been documented to improve the quality of the recovery 
process and reduce the hospital stay and postoperative morbidity, leading to a shorter 
period of convalescence after surgery (White&Kehlet, 2010). 
3.2 Pre-emptive – Preventive analgesia 
The concept of pre-emptive analgesia has its origins in the idea that painful stimuli, if not 
prevented by administration of preoperative analgesic drugs, could lead to spinal 
sensitization and neuroplasticity processes, resulting in increased pain intensity and 
duration after surgery. Many authors have studied the effects of different timing of 
administration of single drugs (e.g., pre-, intra- or postoperative) and have reported no 
differences in efficacy (Moiniche, 2002). 
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This approach does not seem to offer any clinically significant advantages over so-called 
preventative multimodal analgesic regimens when an effective pro-active approach to pain 
management is initiated in the early postoperative period and extended into the 
postdischarge period (Sun, 2008).  Starting with  intensive pain therapy at the beginning and 
analgesia must be continued, using step-down techniques that involve a change in drugs or 
route of administration (i.e., from the epidural and intravenous routes to per os 
administration) (Fanelli, 2008). 
The main goals of preventive analgesia are: to decrease pain after tissue injury, to prevent spinal 
sensitization and to reduce the incidence of inflammatory or chronic pain (Senturk, 2002). 
4. Drugs in postoperative pain management 
Multimodal (or balanced) analgesia represents an increasingly popular approach to 
preventing postoperative pain. The approach involves administering a combination of 
opioid and nonopioid analgesics (and adjuvant agents) that act at different sites within the 
central and peripheral nervous systems in an effort to improve pain control, with fewer 
opioid-related side effects mainly sedation, nausea, vomiting pruritis, constipation (Elvir 
Lazo&White, 2010; Vadivelu, 2010). 
The development of newer agents available for postoperative pain control opens up 
possibilities for newer combinations in multimodal analgesia. Multi-pharmacological 
therapy based on synergistic effects of two or more drugs gives better results than a mono-
pharmacologic approach (Vadivelu, 2010). 
4.1 Opioids 
Opioid analgesics continue to play an important role in the acute treatment of moderate-to-
severe pain in the early postoperative period. The problem about these drugs is the variety 
of perioperative complications eg, drowsiness and sedation, PONV, pruritus, urinary 
retention, ileus, constipation, ventilatory depression of them. These opioid-related adverse 
effects inhibit rapid recovery and rehabilitation (Buvanendran&Kroin, 2009; Vadivelu, 2010). 
Their effects can be summarized as hyperpolarization of first- and second-order sensory 
neurons, with inhibition of synaptic transmission. They act by binding to μ receptors, which 
initially results in increased G protein activity; this, in turn, leads to K+ efflux and inhibition 
of Ca2+ influx into the cell. Opioids also stimulate the supraspinal descending inhibitory 
system, which further increases the hyperpolarization of second-order neurons by releasing 
5-HT and glycine. Opioid receptors have been demonstrated in vitro in peripheral nerve 
terminals, but they are unable to influence the inflammatory reaction, resulting  lack of 
effectiveness on postoperative pain during movement (Christie, 2000). 
Opioids can be used in different ways; i.e intravenous, intramuscular, subcutaneous, 
transmucosal, epidural, intrathecal, transdermal. The most common route of postoperative 
systemic opioid analgesic administration is intravenous. When the most important source of 
nociceptive stimuli is visceral pain, good results may be achieved by intrathecal administration 
of small doses of opioids (Rathmell, 2005). 
Patient controlled analgesia (PCA) optimizes delivery of analgesic opioids and minimizes 
the effects of pharmacokinetic and pharmacodynamics variability in individual patients. It 
can be programmed for several variables: demand (bolus) dose, lockout interval, continuous 
or basal infusion, and 4 h limit (Table 2). PCA provides superior postoperative analgesia 
and improves patient satisfaction when compared with traditional PRN analgesic regimens. 
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Drug *- Concentration Bolus dose 
Lockout interval 
(min) 
Basal-Continuous 
infusion ** 
Morphine (1 mg/ml) 0.5-2 mg 5-10 0-2 mg/h 
Fentanyl (0.01 mg/ml) 10-20 µg 5-10 0-60 µg/h 
Alfentanil (0.1 mg/ml) 0.1-0.2 mg 5-8  
Sufentanil (0.002 mg/ml) 2-5 µg 4-10 0-8 µg/h 
Meperidine (10 mg/ml) 5-25 mg 5-10 0-20 mg/h 
Tramadol (4-5 mg/ml) 10-20 mg 6-10 0-20 mg/ml 
* Individual patient requirements vary widely. Titrated loading doses can be used if necessary to 
establish initial analgesia. 
** Continuous infusions are not initially recommended for opioid-naive adult patients 
Table 2. Intravenous PCA Regimens 
Opioid analgesics will likely remain the primary treatment option for patients who require 
rescue analgesic therapy in the postoperative period until more potent and rapid-acting 
nonopioid analgesics become available for routine clinical use. 
4.1.1 Controlled-release opiods 
Controlled-release opioids are not traditionally considered useful in the immediate 
postoperative period, but some studies have demonstrated that controlled-release 
oxycodone may be used for postoperative pain control when  remifentanil is used for 
maintenance of anesthesia. Its preoperative administration leads to adequate plasma 
concentrations for postoperative analgesia and hyperalgesia treatment following short 
surgery (1-2 h) (Nishimori, 2006). In addition, controlled-release opioids are an optimal 
choice for step-down analgesia in the late postoperative and rehabilitation periods following 
orthopedic surgical procedures (de Beer J de, 2005). 
4.1.2 Tramadol 
Tramadol enhances inhibitory effects on pain transmission at the spinal level blocking 
nociceptive signal transduction both by opioid and monoaminergic mechanisms. Its opioid 
and nonopioid modes of action appear to act synergistically. The drug is available in 
formulations suitable for oral, rectal and parenteral administration. Tramadol has been 
shown to provide effective analgesia after intravenous and oral (in a few of newer clinical 
studies) administration for postoperative pain management. The main advantage of 
tramadol in postoperative analgesia is a relative lack of respiratory depression. The potential 
of abuse is also negligible. 
4.2 Nonopioids 
Opioid analgesics, once considered the standard approach to preventing acute postoperative 
pain, are being replaced by a combination of nonopioid analgesic drugs with diverse modes 
of action as part of a multimodal approach to preventing pain after ambulatory surgery.  
Nonopioid analgesics are increasingly being used before, during, and after surgery to facilitate 
the recovery process especially after ambulatory surgery because of their anesthetic-and 
analgesic-sparing effects and their ability to reduce postoperative pain (with movement), 
opioid analgesic requirement, and side effects, thereby shortening the duration of the hospital 
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stay. Nonopioid analgesics will likely assume a greater role as preventive analgesics in the 
future as the number of minimally invasive (keyhole) surgery cases continues to expand. 
Recent studies have confirmed that a rational combination of different nonopioid analgesics 
when given as part of multimodal analgesia reduces postoperative pain. The use of 
traditional NSAIDs, COX-2 inhibitors, acetaminophen, ketamine, dexmedetomidine, 
dextromethorphan, alpha2-agonists, gabapentin, pregabalin, and glucocorticoid steroids can 
provide beneficial effects when administered in appropriate doses as part of a multimodal 
analgesic regimen in the perioperative  setting (Elvir Lazo&White, 2010). 
Nonopioid drugs used in postoperative pain management can be classified as:   
1. NSAIDs and COX-2 inhibitors  
2. Acetaminophen 
3. Paracetamol 
4. Adjuvants 
a. Alpha-2 adrenergic agonists 
i. Clonidine 
ii. Dexmedetomidine 
b. N-methyl-D-aspartate antagonists (Antihyperalgesic drugs) 
i. Ketamine 
ii. Dextramethorphan 
iii. Magnesium 
c. Gabapentin-type drugs 
i. Gabapentin 
ii. Pregabalin 
d. Glucocorticoids 
i. Dexamethasone 
e. Newer drugs 
i. Capsaicin 
ii. Glyceryl trinitrate 
iii. Cholinergic drugs 
Nicotine 
5. Local Anesthetics 
4.2.1 NSAIDs and cyclooxygenase-2-selective inhibitors 
NSAIDs are known to achieve pain relief by their effect on COX-1 and 2 with the various 
NSAIDs differing in the proportion to which they inhibit COX-1 and COX-2. They are acid 
compounds with analgesic, antipyretic and anti-inflammatory properties via inhibition of 
prostaglandin (PG) synthesis. Prostaglandins, including PG-E2, are responsible for reducing 
the pain threshold at the site of injury, resulting in central sensitization and a lower pain 
threshold in the surrounding uninjured tissue. The primary site of action of NSAIDs is 
believed to be in the periphery though recent research indicates that central inhibition of 
COX-2 may also play an important role in modulating nociception. NSAIDs inhibit the 
synthesis of prostaglandins both in the spinal cord and at the periphery, thus diminishing 
the hyperalgesic state after surgical trauma (Buvanendran&Kroin, 2009; Fanelli, 2008; 
McClane, 2010). 
NSAIDs are administered orally, parenterally or by the rectal route. 
NSAIDs are useful as the sole analgesic after minor surgical procedures. They provide 
moderate postoperative analgesia and thereby have a significant opioid-sparing effect of 20-
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30% after major surgery (Power, 1999).  This may be of clinical importance as NSAIDs may 
reduce the incidence of opioid-related side-effects (respiratory depression, sedation, nausea 
and vomiting, ileus, urinary bladder dysfunction and possibly sleep disturbances).  Since 
the COX-2 enzyme, the primary target of NSAIDs, is inducible, it is not found in damaged 
tissues until a few hours following the onset of a noxious stimulus. This could explain the 
lack of efficacy of preemptive administration of these drugs (Ness, 2001). 
NSAID use is not appropriate in all patients because of their age or renal or hematological 
status or because of previous dyspeptic symptoms (McClane, 2010). COX-2-selective 
inhibitors  (celecoxib, etoricoxib, rofecoxib- is no longer in use due to adverse cardiovascular 
events-) have the advantage over NSAIDs in the perioperative setting of not increasing  the 
risk of bleeding (Buvanendran&Kroin, 2009). 
Many patients now receive a NSAID as a routine part of their postoperative analgesic 
management.  Recent practice guidelines for acute pain management in the perioperative 
setting specifically state ‘unless contraindicated, all patients should receive around-the-clock 
regimen of NSAIDs, COX-2 inhibitors, or acetaminophen’ (Ashburn, et al, 2004). 
4.2.2 Acetaminophen 
Acetaminophen is antipyretic and analgesic but has little, if any, anti-inflammatory action. 
Its analgesic efficacy is not more than that of traditional analgesics; however, it has fewer 
side effects. Preparation of intravenous acetaminophen recently has been released in 
Europe.  A 100 ml solution is presented as 10 mg/ml for administration over a period of 15 
minutes. The onset of action is within five to 10 minutes, with the peak at one to two hours. 
Optimal analgesia for moderate to severe postoperative pain cannot be achieved using a 
single agent alone, but a balanced approach in combination with non-steroidal agents can 
result in up to a 40 to 50 percent reduction in opioid requirements (Vadivelu, 2010). 
4.2.3 Paracetamol 
Paracetamol has antipyretic and analgesic properties, but it is devoid of anti-inflammatory 
effects. It has an inhibitory action on central COX-2 and COX-3 enzymes, which would 
explain its antipyretic activity. The analgesic effect seems to be due to activation of 
descending serotonergic inhibitory pathways as well as inhibition of central NO synthases 
(Graham&Scott, 2005). Similar to other analgesic drugs, paracetamol shows differential 
properties in terms of pain control.  Paracetamol may be more effective in treating 
episiotomy or abdominal pain rather than pain following orthopedic surgery or tooth 
extraction (Gray, et al, 2005; macario&Lipman, 2001). The different relative roles of 
peripheral COX enzymes in postoperative pain may explain these differing efficacies. 
When paracetamol and NSAIDs are administered by an intravenous route, they show 
sparing effects on opioid consumption (about 25% and 30%, respectively); this effect begins 
4 h after their first administration and is synergistic (Elia et al, 2005; Mirande, 2006). 
4.2.4 Adjuvants 
Adjuvant drugs are defined as substances that may improve pain treatment and pain 
control, but they are not commonly defined as analgesics. Adjuvants are compounds, which 
by themselves have undesirable side effects or low potency but in combination with opioids 
allow a reduction of narcotic dosing for postoperative pain control. Thus they can provide 
beneficial effects when administered in appropriate doses as part of a multimodal analgesic 
regimen in the perioperative setting (Fanelli et al, 2008; Vadivelu et al, 2010). 
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Multimodal analgesia incorporates the use of analgesic adjuncts with different mechanisms 
of action to enhance postoperative pain management. Adjuvants are important in 
postoperative pain management due to side effects of opioid analgesics, which hinder 
recovery, especially in the increasingly utilized ambulatory surgical procedures 
(Buvanendran&Kroin, 2007). Multiple adjuvants recently have been developed for the 
control of pain.  
4.2.4.1 Alpha-2 adrenergic agonists 
Alpha-2 adrenergic activation represents an intrinsic pain control network of the central 
nervous system. The alpha-2 adrenergic receptor has high density in the substantia 
gelatinosa of the dorsal horn in humans and that is believed to be the primary site  
of action by which alpha-2 adrenergic agonists can reduce pain (Buvanendran&Kroin, 
2007). 
4.2.4.1.1 Clonidine 
Clonidine is originally classified as an anti-hypertensive drug with negative chronotropic 
activity, but has antinociceptive properties as well. In the spinal cord, clonidine acts at 
alpha-2 adrenergic receptors to stimulate acetylcholine release, which acts at both 
muscarinic and nicotinic receptor subtypes with analgesic effects (Fanelli et al, 2008). 
Clonidine can be administered orally, intravenously, neuraxially  or perineurally in 
combination with local anesthetics. However, the side effects could be significant. The most 
important ones are hypotension, bradycardia and sedation (Rawal). Data about the systemic 
administration of clonidine could support the usefulness of low-dose IV administration. 
Nonetheless due to the many side effects of systemic clonidine administration, the spinal 
route is preferred.   
Low doses of clonidine proved to be a useful adjunct analgesic when given neuraxially and 
in combination with peripheral nerve blocks (Habib et al, 2005). Significant results in terms 
of block duration were obtained when clonidine was added to local anesthetics for epidural 
or perineural analgesia. At low doses (2 μg/kg), it was shown to increase the duration of 
perineural blockade. Animal studies suggest that the mechanism of clonidine’s potentiation 
of lidocaine nerve block is inhibition of the hyperpolarization-activated cation current, not 
via its binding to alpha-2 adrenergic receptors (Jurna, 1995). 
4.2.4.1.2 Dexmedetomidine 
Dexmedetomidine is a relatively new, highly selective central alpha-2 agonist.  
Dexmedetomidine, when used as an adjunct, can reduce postoperative morphine 
consumption in various surgical settings using various routes such as intravenous (Dholakia 
et al, 2007; Gurbet et al, 2006; Lin et al, 2009). In a recent study the authors found that;  
the addition of dexmedetomidine to intravenous  PCA morphine resulted in superior 
analgesia, significant morphine sparing, and less morphine-induced nausea,while it  
was devoid of additional sedation and untoward hemodynamic changes (Dholakia et al, 
2007).   
4.2.4.2 N-methyl-D-aspartate antagonists (Antihyperalgesic drugs) 
With the discovery of the N-methyl-D-aspartate (NMDA) receptor and its links to 
nociceptive pain transmission and central sensitization, there has been renewed interest in 
utilizing noncompetitive NMDA receptor antagonists, such as ketamine, dextromethorphan, 
magnesium ions as potential antihyperalgesic agents. 
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4.2.4.2.1 Ketamine 
Ketamine has been a well known general anesthetic and analgesic for the past 3 decades.  
There is evidence that low-dose ketamine may play an important role in postoperative  
pain management when used as an adjunct to opioids, local anesthetics, and other analgesic 
agents. 
Ketamine, is the most commonly used antihyperalgesic drug. There is a definite role of 
ketamine in preventing opioid-induced hyperalgesia in patients receiving high doses of 
opioid for their postoperative pain relief (Mitra, 2008). It acts as an antagonist of NMDA 
receptors and may reduce the intensity of hyperalgesia following rapid μ opioid receptor 
stimulation by short-acting agonists such as remifentanil and, to a lesser extent, sufentanil 
and fentanyl. Perioperative administration of 2-10 μg/kg/min following a loading dose of 
0.5 mg/kg decreases hyperalgesia and allodynia after thoracic and abdominal surgery 
(Bilgin et al, 2005; Joly et al, 2005), although doses may vary depending on the overall 
duration and amount of exposure to short-acting opioids.  
Routes of administration include oral, intravenous,intramuscular, subcutaneous, epidural, 
transdermal, and intra-articular.  
Clinical use of ketamine can be limited due to psychotomimetic adverse effects such as 
hallucinations, excessive sedation and bad dreams. Other common adverse effects are 
dizziness, blurred vision, and nausea and vomiting  (Bell et al, 2006). Although high doses 
of ketamine have been implicated in causing psychomimetic effects, subanesthetic or low 
doses of ketamine have demonstrated significant analgesic efficacy without these side 
effects (Buvanendran&Kroin, 2009). It can be used in sub-anesthetic doses as an adjunct to 
provide postoperative pain relief in opioid-dependent patients (Mitra et al, 2004). 
4.2.4.2.2 Dextramethorphan 
Dextromethorphan has a similar mechanism of action with a lower affinity for the NMDA 
receptor. Following oral administration, it is rapidly absorbed from the gut and crosses the 
blood-brain barrier. A systematic review of perioperative dextromethorphan treatment for 
acute post-surgical pain concluded that the drug was a safe potential adjunct to classical 
opioid-based analgesia, but the results were inconsistent (Duedahl et al, 2006). 
4.2.4.2.3 Magnesium 
The magnesium ion was the first agent discovered to be an NMDA channel blocker. 
Similarly to ketamine and dextromethorphan, magnesium ions act by blocking the NMDA 
receptor pore. Since magnesium crosses the blood-brain barrier with difficulty in humans, it 
is not clear whether its therapeutic effects are related to NMDA antagonism in the central 
nervous system. 
Several clinical studies have shown that magnesium increases postoperative analgesia, but 
the best dosage regimen remains to be determined (Lysakowski et al, 2007). At very high 
doses, perioperative intravenous magnesium sulfate has been reported to reduce 
postoperative morphine consumption but not postoperative pain scores (Koinig et al, 1998; 
Tramer et al, 1996). 
4.2.4.3 Gabapentin-type drugs 
Pregabalin and gabapentin bind to voltage-gated calcium channels in the spinal cord and 
brain. Both drugs are used for seizures and neuropathic pain. One advantage of pregabalin 
in clinical use is that it has higher bioavailability than gabapentin and linear 
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pharmacokinetics. The gabapentinoid compounds have been used as part of multimodal 
analgesic in the postoperative period. Earlier clinical trials with gabapentin for early 
postsurgical pain have recently been reviewed (Buvanendran&Kroin, 2009).  
4.2.4.3.1 Gabapentin 
Gabapentin, a third-generation anti-epileptic drug, is a structural analogue of Gaba 
Aminobutyric Acid (GABA), an important neurotransmitter in the central nervous system. 
Its main action, however, is to inhibit the alpha2δ subunit of Ca2+ channels with a resultant 
decrease in neuronal hyperexcitability. During the immediate postoperative period, 
however, its activation of descending inhibitory pathways may be more relevant and might 
explain its synergistic effect with opioids (Hurley et al, 2006). 
Most of the reviews and meta-analyses concur that perioperative gabapentin helps to 
produce a significant opioid-sparing effect and probably also improves postoperative pain 
score relative to the control group (Hartrick et al, 2009; Tiipana et al, 2007). 
4.2.4.3.2 Pregabalin 
Pregabalin a structural analog of GABA and a derivative of gabapentin (S+ 3-isobutyl 
GABA). It is a novel drug with a heightened research interest in the analgesic, sedative, 
anxiolytic, and opioid-sparing effects, in various pain settings, including postoperative 
pain. 
Its main advantages may be faster onset and reduced adverse side effects. Some studies 
suggest pregabalin to have effective sedative and opioid-sparing effects (Hartrick et al, 2009; 
Mathiesen et al, 2008), useful characteristics for the control of acute pain. Research on its 
established role as an analgesic adjuvant as a part of multimodal  analgesia for acute pain 
control is ongoing.   
4.2.4.4 Glucocorticoids 
Glucocorticoids, including dexamethasone, have been used to reduce inflammation and 
postoperative pain in surgical procedures (Salerno et al, 2006). Glucocorticoid steroids can 
provide beneficial effects when administered in appropriate doses as part of a multimodal 
analgesic regimen in the perioperative setting (White, 2005, 2007). 
4.2.4.4.1 Dexamethasone 
Dexamethasone is a synthetic glucocorticoid with high potency and a long duration of 
action (half-life: 2 days), and has low mineralocorticoid activity. Although dexamethasone 
reduces PG synthesis, its possible analgesic effects have not yet been demonstrated.  
In patients undergoing total hip arthroplasty under spinal anesthesia with propofol sedation 
a single preoperative intravenous dose of dexamethasone decreased the pain upon standing 
at 24 h compared to placebo (Kardash et al, 2008). In a recent study, it did not reduce 
postoperative pain scores and analgesic requirements after laparoscopic cholecystectomy. 
The main advantage of postoperative dexamethasone is its ability to reduce postoperative 
nausea and vomiting  (Feo et al, 2006). 
4.2.4.5 Newer drugs 
4.2.4.5.1 Capcaisin 
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a non narcotic and acts peripherally. It can 
be used as a cream and also as an injectable analgesic. 
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Capsaicin cream is usually combined with narcotic analgesics and NSAIDs to relieve a 
variety of painful ailments such as back pain, arthritic joint pains, and strains and sprains. 
Injectable capsaicin is used for the control of post operative pain, such as after total knee 
replacement, total hip replacement, hernia repair, shoulder arthroscopy, and bunionectomy 
(Aasvang et al, 2008). Pre-administration of neural blockade before injection of capsaicin 
may greatly decrease the burning discomfort. 
Capsaicin appears to be a relatively safe drug. In the elderly who are sensitive to respiratory 
depression that can occur with opioids, capsaicin can be particularly beneficial as an 
adjuvant. The only absolute contraindication being patient hypersensitivity. Relative 
contraindications include age less than 2 years, patients with elevated liver enzymes, 
patients on ACE inhibitors, and patients showing signs of septic arthritis and joint infections 
(Vadivelu et al, 2010).  
4.2.4.5.2 Glyceryl trinitrate 
The organic nitrates, such as glyceryl trinitrate (GTN), act as nitric oxide donors.  
High dose nitroglyserin patches, such as 30 mg daily, are hyperalgesic, whereas doses less 
than 6 mg per day are analgesic under different circumstances. Previously it has been 
observed that patients with past histories of angina who had spinal block, in which the 
nitroglycerin transdermal patch was applied prophylactically, required fewer analgesic after 
operation (Lauretti et al, 1999). 
4.2.4.5.3 Cholinergic drugs 
Acetylcholine may cause analgesia through direct action on spinal cholinergic muscarinic 
receptors M1 and M3 and nicotinic receptors subtypes. 
4.2.4.5.3.1 Nicotine 
In a study in nonsmoker patients having radical retropubic prostatectomy under general 
anesthesia, the application of a 7 mg nicotine patch 30–60 min before surgery for 
postoperative 24 hrs, resulted with lower cumulative PCA morphine consumption versus 
placebo group. But the intensity of nausea was greater in the nicotine group (Habib et al, 
2008). 
Table 3 summarizes the doses and routes of administration of frequently used drugs.  
 
 Administration Dosage 
OPIOIDS 
Morphine (i) Intravenous. 
(ii) Subcutaneous by 
continuous infusion or 
intermittent boluses via 
indwelling cannula. 
(iii) Intramuscular (not 
recommended due to 
incidence of pain.   
5-10 mg 3-4 hourly). 
IV PCA  
Bolus: 1-2 mg, lockout: 5-15 
min (usually 7-8 min), no 
background infusion. 
Subcutaneous  
0.1-0.15 mg/kg 4-6 hourly, 
adapted in relation to pain 
score, sedation and 
respiratory rate. 
Codeine Oral 3 mg/kg/day combined 
with paracetamol. 
A minimum of 30 mg 
codeine/tablet is required 
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 Administration Dosage 
OPIOIDS 
Tramadol (i) Intravenous: inject 
slowly (risk of high 
incidence of nausea and 
vomiting). 
(ii) Intramuscular. 
(iii) Oral administration as 
soon as possible. 
 
0.75-1.0 mg/kg 
50-100 mg 6 hourly. 
NONOPIOIDS 
Paracetamol  Oral 4 x 1 g paracetamol/day (2 g 
propacetamol/day). 
Dose to be reduced (e.g. 3 x 1 
g/day) in case of hepatic 
insufficiency. 
Combination of 
paracetamol and codeine 
Oral Paracetamol 500 mg + 
codeine 30 mg. 
4 x 1 g paracetamol/day. 
NSAIDs (i) Intravenous 
administration should start 
at least 30-60 min before 
end of surgery. 
(ii) Oral administration 
should start as soon as 
possible. 
Duration: 3-5 days. 
(iii) Rectal 
Ketorolac: 3 x 30-40 mg/day  
(only IV form) 
Diclofenac: 2 x 75 mg/day 
Ketoprofen: 4 x 50 mg/day 
(ii) Selective NSAIDs 
include: 
Meloxicam 15 mg once daily 
Celecoxib: 200 mg/day. 
Acetaminophen Intravenous 100 ml solution (10 mg/ml) 
administration over a period 
of 15 minutes. 
ADJUVANTS 
Clonidine (i) Oral 
(ii) Intravenous 
(iii) Combined with local 
anesthetics-neuraxially or 
perineurally 
3- 5 µg/kg (oral) 
1 µg/kg (intravenous) 
1-2 µg/kg (epidural) or 75-
100 µg (intrathecal) 
Ketamine Intravenous Loading dose of 0.5 mg/kg 
followed by 2-10 µg/kg/min 
* The doses and routes of administration of drugs described above are general examples and each 
patient should be assessed individually before prescribing 
Table 3. The doses and routes of administration of frequently used drugs * (modified table 
by permission from Publisher AstraZeneca) 
4.2.5 Local anesthetics 
Sodium channel blocking drugs are usually used in the management of both acute and 
chronic pain. When dealing with postoperative pain, local anesthetics such as lidocaine and 
bupivacaine mostly preferred (McCleane, 2010). 
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Local anesthetics block sodium channels, thereby, preventing transmission of nerve impulse 
along the axonal fibre. This is a local effect at the site of injection. Tissue anesthesia occurs 
after the injection of the local anesthetics into tissue at appropriate concentration, but it lasts 
after the duration of the drug ended. However, local anesthetics are also absorbed into the 
systemic circulation from the site of injection and, depending on the dose and rate of 
absorption, may have  systemic analgesic effects (Gupta,2010; McCleane, 2010). 
Local anesthetic solutions delivered through an epidural or perineural route are the most 
important treatments for decreasing incident pain, hormonal stress and sympathetic 
responses during and after surgery (Chelly, 2001; Liu, 2007). Generally, higher doses are 
used intraoperatively and then reduced to reach differential motor-sensory block in the 
postoperative period. The best results are achieved when local anesthetic solutions are 
infused neuraxially with lipophilic opioids, such as sufentanil and fentanyl at adequate 
concentrations (George, 2006; de-Leon-Casaola&Lema, 1996). 
In some studies the effectiveness of the intravenous infusion of lidocaine in reducing 
postoperative pain and facilitating the recovery process have been demonstrated (Kaba et al, 
2007; Lauwick et al, 2008). Yardeni and colleagues (Yardeni et al, 2009) suggested that, 
perioperative administration of intravenous lidocaine could improve early postoperative 
pain control and reduce surgery-induced immune alterations. The injection of local 
anesthetic around wound edges has been proven to reduce postoperative pain, but only for 
the duration of that local anesthetic (Moinichi et al, 1998). Several concerns about these 
drugs have been expressed in the literature including the risk of infection, chondrolysis and 
systemic local anesthetics toxicity when they used locally.  
The maximum doses for local anesthetics are summarized in Table 4. 
 
Local anesthetic Maximum total dosage 
Prokain 400 mg 
Chlorprocaine 800 mg 
Lidocaine 4 mg/kg (without epinephrine) 
7 mg/kg(with epinephrine)  or  300 mg 
Prilocaine 6 mg/kg (without epinephrine) 
9 mg/kg(with epinephrine)  or  500 mg 
Bupivacaine 2 mg/kg (without epinephrine) 
2.5 mg/kg(with epinephrine)  or  150 mg 
Levobupivacaine 2.5-3 mg/kg (insufficient data)  or  150 mg  
Ropivacaine 3-4 mg/kg (without or with epinephrine) 
Table 4. Maximum doses of frequently used local anesthetics 
5. Techniques in postoperative pain management 
One approach for multimodal analgesia is the use of regional anesthesia and analgesia to 
inhibit the neural conduction from the surgical site to the spinal cord and decrease spinal cord 
sensitization (Buvanendran&Kroin, 2009). A variety of neuraxial and peripheral regional 
analgesic techniques can provide analgesia superior to that with systemic opioids and may 
even result in improvement in various outcomes.  However, there are some risks associated 
with the use of such techniques. The clinician should evaluate the risks and benefits of these 
techniques on an individual basis in determining the appropriateness of neuraxial or 
www.intechopen.com
 
Multimodal Analgesia for Postoperative Pain Management 
 
193 
peripheral regional techniques for each patient, especially in light of some of the controversies 
about the use of these techniques in the presence of various anticoagulants.    
Neuraxial (primarily epidural) and peripheral regional analgesic techniques (e.g., brachial 
plexus, lumbar plexus, femoral, sciatic-popliteal, and scalp nerve blocks),  also a variety of 
wound infiltration techniques may be used for the effective treatment of postoperative pain. 
In general, the analgesia provided by epidural and peripheral techniques (particularly when 
local anesthetics are used) is superior to that with systemic opioids, (i.e., superior analgesia 
and decreased opioid-related side effects) and use of these techniques may even reduce 
morbidity and mortality (Wu&Fleisher 2000). 
Techniques used in postopetaive pain management are: 
1. Neuraxial Techniques 
2. Peripheral Regional Analgesia Techniques 
3. Infiltration Techniques  
a. Wound Infiltration 
b. Topical Application 
c. Local Infiltration Analgesia 
4. Other – Nonpharmacological Techniques 
5.1 Neuraxial techniques 
Spinal or epidural analgesia techniques in single or continuous forms can be used in 
postoperative pain management. The use of epidural anesthesia and analgesia is an integral 
part of the multimodal approach because of the superior analgesia and physiologic benefits 
conferred by epidural analgesia. 
Among the most commonly used pain-relieving techniques, there is evidence that the 
epidural local anesthetic or local anesthetic-opioid techniques are the most effective on 
providing dynamic pain relief after major surgical procedures (Kehlet et al, 1999). Epidural 
local anesthetic application comes in as the major component of multimodal analgesia. 
Postoperative epidural analgesia is usually accomplished with a combination of a long-
acting local anesthetic and an opioid, in dilute concentrations (Table 5). Long-acting local 
anesthetics are preferred because they are associated with less tachyphylaxis. Thoracic 
epidural analgesia with local anesthetics and opioids for abdominal, thoracic and vascular 
surgery improves bowel recovery times while decreasing the risks of cardiovascular 
adverse events and of developing persistent pain (Liu, 2004; Nishimori et al, 2006;). In an 
unpublished study of ours (Sivrikaya et al, 2000), preemptive analgesia with epidural 
tramadol has supressed the peroperative stress response and also reduced the pain 
intensity in the early postoperative period in patients had abdominal hysterectomy under 
general anesthesia.     
Maintenance techniques in epidural analgesia include: 
Continuous Infusion: An easy technique that requires little intervention. The cumulative 
dose of local anesthetic is likely to be higher and side effects are more likely than with the 
other two techniques. 
Intermittent Top-up: Results in benefits due to frequent patient/staff contact but can 
produce a high staff workload and patients may have to wait for treatment. 
Patient-Controlled Epidural Analgesia (PCEA): This technique produces high patient 
satisfaction and reduced dose requirements compared with continuous infusion. However, 
sophisticated pumps are required and accurate catheter position is important for optimal 
efficacy (Rawal). 
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Local anesthetics / 
opioids 
Ropivacaine 2% (2 mg/ml) or  
Levobupivacaine or 
Bupivacaine  
0.1-0.2% (1-2 mg/ml) 
Sufentanil 0.5-1 μg/ml or 
Fentanyl 2-4 μg/ml or 
Morphine 0.05-0.1 mg/ml or 
Clonidine 5-20 μg/ml 
(clinical application is 
limited by its side effects) or 
Epinephrine 2- 5 μg/ml 
Dosage for continuous 
infusion  
(thoracic or lumbar 
level) 
6-12 ml/h  
Dosage for patient 
controlled infusion  
(thorasic or lumbar 
level) ** 
Background: 4-6 ml/h 
Bolus dose: 2 ml (2-4 ml) 
Minimum lockout interval 10 
min 
(10-30 min) 
Recommended maximum 
hourly dose (bolus + 
background): 12 ml 
 
* The tip of the catheter should be placed as close as possible to the surgical dermatomes: T6-T10 for 
major intra-abdominal surgery, and L2-L4 for lower limb surgery. 
** There are many possible variations in local anesthetic/opioid concentration yielding good results, the 
examples given here should be taken as a guideline; higher concentrations than the ones mentioned 
here are sometimes required but cannot be recommended as a routine for postoperative pain relief. 
Table 5. Examples of local anesthetics and opioids and doses in epidural analgesia *  
(by permission from Publisher AstraZeneca) 
Continuous central neuraxial blockade is one of the most effective forms of postoperative 
analgesia, but it is also one of the most invasive. However, this technique remains the  
first choice for a number of indications, such as abdominal, thoracic, and major  
orthopedic surgery, where adequate pain relief cannot be achieved with other analgesia 
techniques alone. Continuous central neuraxial blockade can be achieved via two routes: 
Continuous epidural analgesia - the recommended first choice and continuous spinal 
analgesia - should be limited to selected cases only, as there is less experience with this 
technique.   
5.2 Peripheral regional analgesia techniques 
It is clear that local anesthetic techniques, particularly peripheral nerve blockade, will be 
one of the cornerstones of postoperative pain management. A variety of peripheral 
regional analgesic techniques (e.g. brachial plexus, lumbar plexus, femoral, paravertebral 
nerve blocks) as a single injection or continuous infusion can be used to enhance 
postoperative analgesia. Peripheral regional techniques may have several advantages over 
systemic opioids (i.e., superior analgesia and decreased opioid-related side effects). Also 
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the side effects associated with central neuraxial blockade, such as hypotension and wide 
motor blockade with reduced mobility and proprioception, and complications such as 
epidural Hematoma, epidural abscess and paraparesis can be avoided (Liu&Salinas, 
2003). 
Continuous peripheral nerve blocks are being increasingly used since they may provide 
more selective but still excellent postoperative analgesia with reduced need for opioids over 
an extended period (Table 6). The vailability of disposable local anesthetic infusion systems 
and the encouraging results from these early studies have led to the increasing popularity of 
these techniques for pain control in the postdischarge period (Elvir Lazo&White, 2010). This 
technique has become increasingly popular due to its ability to control moderate to severe 
pain  and accelerate recovery especially after orthopedic surgery procedures (Capdevila et 
al, 2005; Ilfeld&Enneking, 2005; White, 2003).  
Patient controlled regional analgesia (PCRA) can also be used to maintain peripheral nerve 
block. A low basal infusion rate (e.g. 3-5 ml/h) associated with small PCA boluses (e.g. 2.5-5 
ml - lockout: 30-60 min) is the preferred technique (Rawal). 
 
 
 
Site of catheter Local anesthetics and dosage* 
 Ropivacaine 0.2%-0.375% 
Bupivacaine 0.1-0.125% 
Levobupivacaine 0.1-0.2% 
Interscalene 5-9 ml/h 
Infraclavicular 5-9 ml/h 
Axillary 5-10 ml/h 
Femoral 7-10 ml/h 
Popliteal 3-7 ml/h 
Patient controlled regional analgesia Background: 3-5 ml/h 
Bolus dose: 2,5-5 ml 
Lockout interval: 30-60 min 
*Sometimes, higher concentrations are required in individual patients. As a standard, starting with a 
low concentration/dose is recommended to avoid sensory loss or motor block. 
Table 6. Examples of local anesthetics and doses in continuous peripheral nerve analgesia 
and PCA (modified table after using by permission from Publisher AstraZeneca) 
5.2.1 Paravertebral blocks 
The evidence suggests that the use of paravertebral blocks provide effective postoperative 
pain control following breast and thoracic surgery as well as for inguinal hernia repair 
(Greengrass et al, 1996; Karmakar, 2011; Pusch et al, 1999). On their own, paravertebral 
blocks have been demonstrated to provide effective postoperative analgesia lasting up to  
24 hrs (Chelly et al, 2011). 
Chelly et al showed in their study that; a multimodal approach, including paravertebral 
blocks (prior to surgery), celecoxib (pre and post surgey), and ketamine (immediately prior 
to surgery), provides better postoperative pain control than PCA morphine alone in patients 
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undergoing open radical retropubic prostatectomy. This approach also allows a reduction in 
the postoperative need for opioids, lessens the related side effects (e.g., PONV, constipation, 
and bladder spasm), and facilitates earlier patient recovery which can be connoted that it 
fascilitates the patient’s early recovery (Chelly et al, 2011).    
5.3 Infiltration techniques 
Local anesthetics can be administered for perioperative pain management via different routes 
(Table 7). It is crucial for improving the perioperative outcomes especially after day-case 
surgery (White&Kehlet, 2010). 
 
 
 
 Local anesthetic Volume Additives 
Intraarticular instillation  
Knee arthroscopy 0.75% Ropivacaine 20 ml Morphine 1-2 
mg 
0.5% Bupivacaine 20 ml Morphine 1-2 
mg 
Shoulder arthroscopy 0.75% Ropivacaine 10-20 ml  
Intraperitoneal 
instillation 
 
Gynecological 0.75% Ropivacaine 20 ml  
Cholecystectomy 0.25% Ropivacaine 40-60 ml  
Wound infiltration  
Inguinal hernia 
Perianal surgery 
0.25-0.5% Ropivacaine 30-40 ml  
0.25-0.5% 
Levobupivacaine 
30-40 ml  
0.25-0.5% Bupivacaine Up to 30 ml  
Thyroid surgery 0.25-0.5% Ropivacaine 10-20 ml  
0.25-0.5% 
Levobupivacaine 
10-20 ml  
0.25-0.5% Bupivacaine Up to 20 ml  
Table 7. Local anesthetic infiltration  (by permission from Publisher AstraZeneca) 
There are a few techniques for the delivery of the drugs locally into the tissues: intermittent 
injection, continuous infusion or a combination of two: Intermittent injections (also 
sometimes referred to as patient-controlled regional analgesia) have the advantage that pain 
relief can be timed in order to achieve maximal effect during the painful periods such as 
during mobilization. However, the disadvantage is that sleep quality may be disturbed, as 
patients sometimes wake up at night due to severe pain, which may be annoying and can 
also be a cause of patient dissatisfaction. Continuous local anesthetic administration has its 
advantage in that the patient has adequate pain relief most of the time. However, during 
periods of activity, the pain could be more severe, which may hamper mobilization. 
Methods using pumps that have a dual function with low-dose continuous infusion 
combined with self-administered bolus doses during mobilization are ideal. Several such 
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pumps are available in the market today, including mechanical (elastometric) and electronic 
(Gupta, 2010).  
5.3.1 Wound infiltration 
Infiltrating local anesthetics into the skin and subcutaneous tissue prior to making an 
incision may be the simplest approach to analgesia. It is a safe procedure with few side 
effects and low risk for toxicity. Particularly, local anesthetic toxicity, wound infection and 
healing do not appear to be major problems (Buvanendran&Kroin, 2009).  
Although the benefit of local wound infiltration has been documented (Barr-Dayan et al, 
2004; Legeby et al, 2009; Park et al, 2002), controversy exists as to the appropriate timing of 
administering local anesthesia for surgery. A single injection of local anesthetics into the 
wound is unlikely to have long-lasting effects. Therefore, new techniques for wound 
infiltration have evolved during the last 10 years and several of them are today used 
routinely during ambulatory surgery and even in the inpatient setting. One such technique 
is the use of catheters inserted into incision, fascia, intra-articularly and intraabdominally for 
the intermittent injection or continuous infusion of local anesthetics and adjuvants for pain 
management (Gupta, 2010). 
Continuous wound infusion of local anesthetics, which is mainly used in general surgery 
and orthopedics, is an interesting technique in postoperative pain therapy. Continuous 
wound infusion of local anesthetics is able to reduce postoperative opioid requirements and 
results in decreased pain scores (Gupta et al, 2004; Rasmussen et al, 2004). Recent studies 
indicate that rehabilitation seems to be enhanced and postoperative hospital stay may be 
shorter. Continuous wound infusion is an effective analgesic technique, which is simple to 
perform. Comparisons with other analgesic techniques, such as peripheral nerve blocks, 
epidural analgesia and other multimodal analgesic concepts are still required.  
Hollmann and Durieux (Hollmann&Durieux, 2000) found that there was a reduction in ileus 
and hospital stay when lidocaine was given intravenously following major abdominal 
surgery. Therefore, when administered in larger doses during wound infiltration analgesia, 
it is possible that some of the analgesic effect seen is via systemic absorption and anti-
inflammation.   
Wound infiltration with local anesthetics is a simple, effective and inexpensive way of 
regimen which can be used in a multimodal analgesic regime without major complications. 
Nonetheless this technique still open some questions to be answered as; to the site of 
catheter placement, catheter type to be placed, the drugs and concentrations recommended, 
the technique of administration and side-effects of the technique, including toxicity of local 
anesthetics.  Also it remains unclear as to whether this technique is useful in all types of 
surgery or should preferably be used for specific operations (Gupta, 2000).  
5.3.2 Topical application 
5.3.2.1 Local anesthetics 
Lidocaine patches were applied to the wound area in the next two studies, and the evidence 
shows that these are particularly effective for wound pain when the patient coughes and 
they reduce the postoperative pain score at discharge (Habib et al, 2009; Saber et al, 2009).  
To place lidocaine patches over or at least close to the wound is suggested as a safe and 
promising modality to consider in the management of postoperative pain control.  
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5.3.2.2 Clonidine 
Clonidine is an alpha adrenoreceptor agonist and these receptors are known to be located 
centrally. In a volunteer study (Pratab et al, 2007) clonidine had a significant peripheral 
action in enhancing duration of local anesthesia on superficial co-infiltration with lidocaine. 
Hence an opportunity with this co-administration to prolong the duration of pain relief 
apparent after postoperative wound infiltration could be possible.  
5.3.2.3 Nonsteroidal anti-inflammatory drugs 
The topical application of NSAIDs could produce significant pain relief as the systemic 
levels achieved by transdermal application. Topically use of NSAIDs has become popular in 
the ophthalmic field, in which it has been shown that topically applied NSAIDs can reduce 
postoperative pain and inflammation (Cho, 2009; Jones&Francis, 2009). In a study, the use of 
a topical diclofenac patch resulted with reduced wound pain and analgesic requirement in 
patients who have undergone laparoscopic gynecologic surgery (Alessandri et al, 2006). As 
a result NSAID patch formulations, to be placed directly over the wound, would have a 
useful pain-relieving effect. But there is still some studies needed to compare this  
application with systemic administration of the same drug and what the side effect 
frequency might be with such application (McCleane, 2010). 
5.3.2.4 Glyceryl trinitrate 
Experimental data suggest that the production of endogenous nitric oxide is necessary for 
tonic cholinergic inhibition of spinal pain transmission. In a study; transdermal nitroglycerin 
and the central cholinergic agent neostigmine have enhanced each other's antinociceptive 
effects at the dose studied (Lauretti et al, 2010).  In two recent more studies transdermal 
nitroglycerin enhanced the analgesic effect of intrathecal neostigmine following abdominal 
hysterectomy (Ahmed et al, 2010)  and intrathecal fentanyl with bupivacaine following 
gynecological surgery (Gang et al, 2010).     
5.3.3 Local infiltration analgesia 
The administration of large volumes of local anesthetics with or without adjuvants into 
different tissue planes perioperatively is called local infiltration analgesia (LIA) (Gupta, 
2010). 
It is a multimodal technique developed by Kerr et al. (Kerr at al, 2008) for the control of pain 
following knee and hip surgery. In their study it was based on systematic infiltration of a 
mixture of a long acting local anesthetics (ropivacaine), a NSAID (ketorolac), and adrenaline 
into the tissues around the surgical field (periarticularly intraoperatively and via an intra-
articular catheter postoperatively) to achieve satisfactory pain control with little 
physiological disturbance. The technique allows virtually immediate mobilization and 
earlier discharge from hospital. A recent study by Essving et al  (Essving et al, 2009) on 
unicompartmental knee arthroplasty  performed with minimal invasive technique, using the 
LIA technique found significantly shorter hospital stay, lower morphine consumption and 
pain intensity compared with placebo. 
5.4 Other – Nonpharmacological techniques 
A number of non-pharmacological methods of pain management may be used in 
conjunction with pharmacological methods in the postoperative setting. These 
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nonpharmacologic techniques, such as transcutaneous electrical nerve stimulation, 
acupuncture, psychological approaches (cold) and relaxing therapy and distraction, can be 
used in an attempt to alleviate postoperative pain.    
5.4.1 Transcutaneous electrical nerve stimulation (TENS) 
The use of TENS at paravertebral dermatomes corresponding to the surgical incision and/or 
acupoints  has also been reported to improve postoperative pain management (Chen et al, 
1998). Because this technique cause few if any adverse effects, its use as an adjunct to 
conventional pharmaceutical approaches should be considered as part of multimodal 
analgesic regimens in the future, particularly for patients in whom conventional analgesic 
techniques fail and/or are accompanied by severe medication-related adverse events (Chen 
et al, 1998; Usichenko, 2007; Wang et al, 1997). 
5.4.2 Acupuncture 
The term acupuncture describes a family of procedures involving the stimulation of anatomical 
points on the body using a variety of techniques. Acupuncture theory is based on two 
conditions: “yin,” which is considered feminine, passive, dark, and cold, and “yang,” which is 
masculine, aggressive, bright, and hot, as well as “qi,” which is considered the vital energy that 
flows and cycles throughout the body. The acupuncture theory is to harmonize any imbalance 
in yin-yang and qi in a human body to restore the body to a healthy condition. Acupuncture is  
thought to unblock any obstruction to the flow of qi and, thereby, relieves pain.  
Usichenko et al. (Usichenko, 2008) focused on randomized controlled trials of only auricular 
acupuncture (a popular method in which needles are placed in various parts of the earlobe) 
for postoperative pain control. They identified nine studies of acceptable quality (though 
none of the best quality), and concluded that the evidence that auricular acupuncture 
controls postoperative pain is promising but not compelling. Sun et al. (Sun et al, 2008) 
conducted a systematic review to quantitatively evaluate the efficacy of acupuncture and 
related techniques as adjunct analgesics for acute postoperative pain management. The 
authors concluded that perioperative acupuncture might be a useful adjunct for acute 
postoperative pain management. However, there are issues with applicability and 
generalizability of the procedure (Lee&Chan, 2006).     
5.4.3 Cold 
Iced-water or continuous flow cold therapy is used in orthopedic surgery after knee-surgery 
(Barber et al, 2000). It can be used both at hospital and at home. There are commercial 
systems, which are easy to use. The use of iced-water in other kinds of surgery needs further 
investigation.   
5.4.4 Relaxing therapy and distraction 
Music, or imagery, or hypnosis may have a positive effect in individual cases. There are 
commercial music CDs available for relaxation (Rawal).   
6 Special aspects 
6.1 Ambulatory procedures 
The percentage of surgical procedures being performed on an outpatient basis continues to 
rise. Many more complex and potentially painful procedures in comorbid conditions of the 
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surgical outpatients are being routinely performed in the ambulatory setting (White & 
Kehlet, 2010).  
Postoperative pain management have some disadvantages in this population; a. pain after 
minor surgery or in ambulatory patients is more difficult to treat because many of the 
aforementioned techniques are not available or are too risky.  b. The increasing number and 
complexity of elective operations that are being performed on an ambulatory (or short-stay) 
basis in which the use of conventional opioid-based intravenous patient controlled analgesia 
and central neuraxial (spinal and epidural) analgesia techniques are simply not practical for 
acute pain management. c. The pressure to discharge patients after surgery could limit the 
pain medications health care professionals are willing to prescribe and it may explain the 
inadequate management of acute pain after surgery.    
Most common medical causes of delayed discharge after ambulatory surgery are; pain, 
drowsiness and nausea/vomiting (Vadivelu et al, 2010). Although many factors, in addition 
to pain, must be carefully controlled to minimize postoperative morbidity and facilitate the 
recovery process after elective surgery, the adequacy of pain control should remain a major 
focus of health care providers, caring for patients undergoing ambulatory surgical 
procedures (Elvir Lazo&White, 2010). Many patients undergoing ambulatory surgery 
continue to experience unacceptably high levels of pain after their operation.  A survey by 
McGrath et al. showed that 30% of patients suffer moderate-to-severe pain following minor 
surgical procedures (McGrath et al, 2004). 
To have a qualified postoperative pain control after ambulatory surgery, it is required that 
patient discharge is not delayed and that pain control remains effective once the patient is 
at home. It is important to avoid to use of long acting analgesics and to use regional 
anesthesia techniques for the anesthesia. Regional analgesia techniques offer a number of 
advantages for day case surgery patients such as: flexible duration of analgesia (with 
single shot techniques and/or with catheter infusions), flexible intensity of blockade 
(according to the type, concentration and volume of local anesthetic) and reduced need 
for opioids. Wound infiltration, intraperitoneal instillation, peripheral nerve blocks e.g. 
brachial plexus, paravertebral, femoral nerve blocks can be used in ambulatory surgery 
patients.  
The adaptation of multimodal (or balanced) analgesic techniques as the standard approach 
for the prevention of pain in the ambulatory setting is one of the keys to improving the 
recovery process after day-case surgery (McGrath et al, 2004; White, 2007). Early studies 
evaluating approaches to facilitating the recovery process have demonstrated that the use of 
multimodal analgesic techniques can improve early recovery as well as other clinically 
meaningful outcomes after ambulatory surgery. These benefits have been confirmed in more 
recent studies (Elvir Lazo&White, 2010). 
An aggressive multimodal perioperative analgesic regimen that provides effective pain 
relief, has minimal side-effects, is intrinsically safe, and can be managed by the patient 
and their family members away from a hospital or surgical center is the ideal one. Current 
evidence suggests that these improvements in patient outcome related to pain control  
can best be achieved by using a combination of preventive analgesic techniques involving 
both centrally and peripherally acting analgesic drugs, as well as novel approaches  
to administering drugs in locations remote from the hospital setting (White&Kehlet,  
2010).   
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Nonopioid analgesics are increasingly being used as adjuvant before, during, and after 
surgery to facilitate the recovery process after ambulatory surgery because of their 
anesthetic and analgesic-sparing effects, their ability to reduce postoperative pain (with 
movement), and their opioid related side-effects (e.g., gastrointestinal and bladder 
dysfunction), thereby shortening the duration of the hospital stay and the convalescence 
period (White&Kehlet, 2010).   
Patient-controlled regional analgesia (PCRA) encompasses a variety of techniques that 
provide effective postoperative pain relief without systemic exposure to opioids.  Using 
PCRA, patients control the application of pre-programmed doses of local anesthetics, most 
frequently ropivacaine or bupivacaine (occasionally in combination with an opioid), via an 
indwelling catheter, which can be placed in different regions of the body depending upon 
the type of surgery. It is important to use suitable local anesthetics in low concentration and 
to inform patient adequately to avoid the risk of local anesthetic toxicity (Rawal, Vadivelu et 
al, 2010).  
6.2 Stress response 
Many detrimental pathophysiologic effects occur in the perioperative period and are 
associated with activation of nociceptors and the stress response. Uncontrolled pain may 
result in activation of the sympathetic nervous system, which can cause a variety of 
potentially harmful physiologic responses that may adversely influence the extent of 
morbidity and mortality (Vadivelu et al, 2010).  
As afferent neural stimuli and activation of the autonomic nervous system and other 
reflexes by pain may serve as a major release mechanism of the endocrine metabolic 
responses and thus contribute to various organ dysfunctions, pain relief may be a powerful 
technique to modify surgical stress responses. 
Systemic opioids (PCA or intermittent), NSAID, epidural opiod, lumbar and thorasic 
epidural local anesthetics are analgesic techniques are mostly used to supress the 
postoperative surgical stress responces but there is a pronounced differential effect of these 
various techniques on surgical stress responses (Kehlet&Holte, 2001). Any treatment with 
opioids, being epidural or PCA opioids, has very little effect on surgical stress responses and 
organ dysfunctions. Same applies to clonidine and also NSAIDs. Epidural anesthesia has the 
most profound inhibitory effect on surgical stress responses. 
Several studies investigating lower extremity surgery have shown continuous lumbar 
epidural local anesthetic techniques to be most effective, probably because of a more 
effective afferent blockade. In abdominal procedures, there is a somewhat smaller efficacy of 
thoracic epidural local anesthetic techniques in modulating endocrine-metabolic responses, 
probably due to insufficient afferent blockade as well as the presence of other release 
mechanisms in eliciting the surgical stress response. 
The neuraxial application of local anesthetics and opioids combined to general anesthesia 
(especially in patients undergoing major abdominal or thoracic procedures) as a multimodal 
strategy can provide superior pain relief, reduced hormonal and metabolic stress, enhanced 
normalization of gastrointestinal function, and thus a shortened postoperative recovery 
time, facilitating mobilization and physiotherapy (Schug&Chong, 2009). In a study by 
Sivrikaya et al (Sivrikaya et al, 2008) general anesthesia combined lumbar epidural analgesia 
can only partially attenuate the peroperative stress response and has some limited effects on 
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recovery of gastrointestinal functions, nevertheless provided a better postoperative 
analgesia compared to general anesthesia alone. Epidural opioid techniques are less 
effective on the stress response, and are comparable with systemic opioid techniques and 
the use of NSAIDs. More data on the use of multimodal analgesic techniques with 
combinations of different analgesics are needed on this issue.  
7. Conclusion 
Postoperative pain is a complication of surgery, which, in turn, complicates recovery with 
functional impairment and drug-related adverse effects.  Despite an increased focus on pain 
management programs and the development of new standards for pain management, many 
patients continue to experience intense pain after surgery. 
Many factors must be considered before deciding on the type of pain therapy to be provided 
to the surgical patient. These include the patients’ co-morbid conditions, psychological 
status, exposure to analgesic therapies, and the type of surgical procedure.    
The multimodal approach may potentially decrease perioperative morbidity, reduce the 
length of hospital stay, and improve patient satisfaction without compromising safety. 
However, widespread implementation of these programs requires multidisciplinary 
collaboration, change in the traditional principles of postoperative care, additional 
resources, and expansion of the traditional acute pain service. Although a multi-
pharmacologic approach may be universally recommended, drugs and their route of 
administration must be changed according to the type of surgery and hospital resources, 
and of course to the patient needs.  
8. References 
Aasvang E, Hansen J, Malmstrøm J, Asmussen T, et al (2008). The effect of wound 
instillation of a novel purified capsaicin formulation on postherniotomy pain: a 
double-blind, randomized, placebo-controlled study. AnesthAnalg, Vol.107, 
No.1(Jul), pp.282-91, ISSN 0003-2999. 
Acute pain management: operative or medical procedures and trauma, part 1 (1992). 
Agency for Health Care Policy and Research. Clin Pharm , Vol.11, No.4(Apr), 
pp.309-31. ISSN 0278-2677. 
Ahmed F, Garg A, Chawla V, Khandelwal M (2010). Transdermal nitroglycerine enhances 
postoperative analgesia of intrathecal neostigmine following abdominal 
hysterectomies. Indian J Anaesth, Vol.54, No. 1(Jan), pp.24-8, ISSN 0019-5049. 
Alessandri F, Lijoi D, Mistrangelo E, Nicoletti a, et al (2006). Topical diclofenac patch for 
postoperative wound pain in laparoscopic gynaecologic surgery: a randomized 
study. J Minim Invasive Gynecol, Vol.13, No.3(May-June), pp.195-200, ISSN 1553-
4650. 
American Pain Society Quality of Care Committee. Quality improvement guidelines for the 
treatment of acute pain and cancer pain (1995). JAMA , Vol.274, No.23(Dec), 
pp.1874-80, ISSN 0098-7484. 
American Society of Anesthesiologists Task Force on Acute Pain Management (2004). 
Practice guidelines for acute pain management in the perioperative setting. An 
www.intechopen.com
 
Multimodal Analgesia for Postoperative Pain Management 
 
203 
updated report by the American Society of Anesthesiologists task force on acute 
pain management. Anesthesiology, Vol.100, No.6(June), pp.1573-81, ISSN 0003-3022. 
Apfelbaum J, Chen C,Mehta S, Gan T (2003). Postoperative pain experience: results from a 
national survey suggest postoperative pain continues to be undermanaged. Anesth 
Analg, Vol.97, No.2(Aug), pp.534-40, ISSN 0003-2999. 
Barber FA. A comparison of crushed ice and continuous flow cold therapy (2000). Am J Knee 
Surg, Vol.13, No.2(Spring), pp.97-101, ISSN 0899-7403. 
Bar-Dayan A, Natour M, Bar-Zakai B, Zmora O, et al (2004). Preperitoneal bupivacaine 
attenuates pain following laparoscopic inguinal hernia repair. Surg Endosc, Vol.18, 
No.7(Jul), pp.1079-81, ISSN 0930-2794. 
Bell R, Dahl J, Moore R, Kalso E. Perioperative ketamine for acute postoperative pain (2006). 
Cochrane Database Syst Rev, Vol.25, No.1(Jan), CD004603, ISSN 1469-
493X(Electronic). 
Bilgin H, Ozcan B, Bilgin T, Kerimoglu B, et al (2005). The influence of timing of systemic 
ketamine administration on postoperative morphine consumption. J Clin Anesth, 
Vol.17, No.8(Dec), pp.592-7, ISSN 0952-8180. 
Birnbach DJ, Johnson MD, Arcario T, Datta S, et al (1989). Effect of diluent volume on 
analgesia produced by epidural fentanyl. Anesth Analg, Vol.68, No.6(Jun), pp.808-
10, ISSN 0003-2999. 
Bisgaard T (2006). Analgesic treatment after laparoscopic cholecystectomy: a critical 
assessment of the evidence. Anesthesiology, Vol.104, No.4(Apr), pp.835-46, ISSN 
0003-3022. 
Boisseau N, Rabary O, Padovani B, Staccini P, et al (2001). Improvement of 'dynamic 
analgesia' does not decrease atelectasis after thoracotomy. Br J Anaesth, Vol.87, 
No.4(Oct), pp.564-9, ISSN 0007-0912. 
Buvanendran A, Kroin J (2007). Useful adjuvants for postoperative pain management. Best 
Pract Res Clin Anaesthesiol, Vol.21, No.1(Mar), pp.31-49, ISSN 1521-6896. 
Buvanendran A, Kroin JS (2009). Multimodal analgesia for controlling acute postoperative 
pain. Curr Opin Anaesthesiol, Vol.22, No.5(Oct), pp.588-93, Review, ISSN 0952-7907. 
Buvanendran A, Kroin JS, Della Valle CJ, Kari M, et al (2010). Perioperative oral pregabalin 
reduces chronic pain after total knee arthroplasty: a prospective, randomized, 
controlled trial. Anesth Analg, Vol.110, No.1(Jan), pp.199-207, ISSN 0003-2999. 
Camann W, Abouleish A, Eisenach J, Hood D, et al (1998). Intrathecal sufentanil and 
epidural bupivacaine for labor analgesia: dose-response of individual agents and in 
combination. Reg Anesth Pain Med, Vol.23, No.5(Sep-Oct), pp.457-62, ISSN 0952-
7907. 
Capdevila X, Pirat P, Bringuier S, Gaertner R, et al (2005). Continuous peripheral nerve 
blocks in hospital wards after orthopedic surgery: a multicenter prospective 
analysis of the quality of postoperative analgesia and complications in 1,416 
patients. Anesthesiology, Vol.103, No.5(Nov), pp.1035-45, ISSN 0003-3022. 
Carli F, Mayo N, Klubien K, Schricker T, et al (2002). Epidural analgesia enhances functional 
exercise capacity and health-related quality of life after colonic surgery: results of a 
randomized trial. Anesthesiology, Vol.97, No.3(Sep), pp.540-9, ISSN 0003-3022. 
Carr DB, Goudas LC (1999). Acute pain. Lancet, Vol.353(9169), No.12(Jun), pp.2051-8, 
Review, ISSN 0140-6736. 
www.intechopen.com
 
Pain Management – Current Issues and Opinions 
 
204 
Chelly JE (2001). General concepts and indications. In: Chelly JE, Casati A, Fanelli G, editors. 
Continuous peripheral nerve block techniques. London: Mosby, pp.11-21. 
Chelly JE, Ploskanych T, Dai F, Nelson JB (2011). Multimodal analgesic approach 
incorporating paravertebral blocks for open radical retropubic prostatectomy: a 
randomized double-blind placebo-controlled study. Can J Anaesth, Vol.58, 
No.4(Apr), pp.371-8, ISSN 0832-610X. 
Chen L, Tang J, White PF, Sloninsky A, et al (1998). The effect of location of transcutaneous 
electrical nerve stimulation on postoperative opioid analgesic requirement: 
acupoint versus nonacupoint stimulation. Anesth Analg, Vol.87, No.5(Nov), 
pp.1129-34, ISSN 0003-2999. 
Cho H, Wolf KJ, Wolf EJ (2009). Management of ocular inflammation and pain following 
cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol, Vol.3, 
pp.199-210, ISSN 1177-5467. 
Christie MJ, Connor M, Vaughan CW, Ingram SL, et al (2000). Cellular actions of opioids and 
other analgesics: implications for synergism in pain relief. Clin Exp Pharmacol 
Physiol, Vol.27, No.7(Jul), pp.520-3, ISSN 0305-1870. 
de Beer Jde V, Winemaker MJ, Donnelly GA, Miceli PC,  et al (2005).  Efficacy and safety of 
controlled release oxycodone and standard therapies for postoperative pain after 
knee or hip replacement. Can J Surg, Vol.48, No.4(Aug), pp.277-83, ISSN 0008-428X. 
de Leon-Casasola OA, Lema MJ (1996). Postoperative epidural opioid analgesia: what are 
the choices? Anesth Analg, Vol.83, No.4(Oct), pp.867-75, ISSN 0003-2999. 
Dholakia C, Beverstein G, Garren M, Nemergut C, et al (2007). The impact of perioperative 
dexmedetomidine infusion on postoperative narcotic use and duration of stay after 
laparoscopic bariatric surgery. J Gastrointest Surg, Vol.11, No.11(Nov), pp.1556-9, 
ISSN 1091-255X. 
Dolin SJ, Cashman JN, Bland JM (2009). Effectiveness of acute postoperative pain 
management: I. Evidence from published data.  Br J Anaesth, Vol.89, No.3(Sep), 
pp.409-23, ISSN 0007-0912. 
Duedahl TH, Romsing J, Moiniche S, Dahl JB (2006). A qualitative systematic review of peri-
operative dextromethorphan in post-operative pain. Acta Anaesthesiol Scand, Vol.50, 
No.1(Jan), pp.1-13, ISSN 0001-5172. 
Eccleston C (2001). Role of psychology in pain management.  Br J Anaesth, Vol.87, No.1(Jul), 
pp.144-52, Review, ISSN 0007-0912. 
Elia N, Lysakowski C, Tramèr MR (2005). Does multimodal analgesia with acetaminophen, 
nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and 
patient-controlled analgesia morphine offer advantages over morphine alone? 
Meta-analyses of randomized trials. Anesthesiology, Vol.103, No.6(Dec), pp.1296-
304, ISSN 0003-3022. 
Elvir-Lazo OL, White PF (2010). Postoperative pain management after ambulatory surgery: 
role of multimodal analgesia. Anesthesiol Clin, Vol.28, No.2(Jun), pp.217-24, ISSN 
1932-2275. 
Essving P, Axelsson K, Kjellberg J, Wallgren O, et al (2009). Reduced hospital stay, morphine 
consumption, and pain intensity with local infiltration analgesia after 
unicompartmental knee arthroplasty. Acta Orthop, Vol.80, No.2(Apr), pp.213-9, 
ISSN 1745-3674. 
www.intechopen.com
 
Multimodal Analgesia for Postoperative Pain Management 
 
205 
Fanelli G, Berti M, Baciarello M (2008). Updating postoperative pain management: from 
multimodal to context-sensitive treatment. Minerva Anestesiol, Vol.74, No.9, pp 489-
500, ISSN 0375-9393. 
Feo CV, Sortini D, Ragazzi R, De Palma M, et al (2006). Randomized clinical trial of the effect 
of preoperative dexamethasone on nausea and vomiting after laparoscopic 
cholecystectomy. Br J Surg, Vol.93, No.3(Mar), pp.295-9, ISSN 0007-1323. 
Gajraj N, Joshi G (2005). Role of cyclooxygenase-2 inhibitors in postoperative pain  
management. Anesthesiol Clin North America, Vol.23, No.1(Mar), pp.49-72, ISSN 
0889-8537. 
Gan TJ, Joshi GP, Viscusi E, Cheung RY, et al (2004). Preoperative parenteral parecoxib and 
follow-up oral valdecoxib reduce length of stay and improve quality of patient 
recovery after laparoscopic cholecystectomy surgery. Anesth Analg, Vol.98, 
No.6(Jun), pp.1665-73, ISSN 0889-8537. 
Garg A, Ahmed F, Khandelwal M, Chawla V, et al (2010). The effect of transdermal 
nitroglycerine on intrathecal fentanyl with bupivacaine for postoperative analgesia 
following gynaecological surgery. Anaesth Intensive Care, Vol.38, No.2(Mar), pp.285-
90, ISSN 0310-057X.      
George MJ (2006). The site of action of epidurally administered opioids and its relevance to 
postoperative pain management. Anaesthesia, Vol.61, No.1(Jul), pp.659-64, ISSN 
0003-2409. 
Graham GG, Scott KF (2005). Mechanism of action of paracetamol. Am J Ther, Vol.12, 
No.1(Jan-Feb), pp.46-55, ISSN 1075-2765. 
Gray A, Kehlet H, Bonnet F, Rawal N (2005). Predicting  postoperative  analgesia  outcomes:  
NNT  league tables  or procedure-specific evidence? Br J Anaesth, Vol.94, No.6(Jun), 
pp.710-4, ISSN 0007-0912. 
Greengrass R, O’Brien F, Lyerly K, Hardman D, et al (1996). Paravertebral block for breast 
cancer surgery. Can J Anaesth, Vol.43, No.8(Aug), pp.858-61, ISSN 0832-610X. 
Gupta A, Perniola A, Axelsson K, Thörn SE, et al (2004). Postoperative pain after abdominal 
hysterectomy: a double-blind comparison between placebo and local anesthetic 
infused intraperitoneally. Anesth Analg, Vol.99, No.4(Oct), pp.1173-9, ISSN 0003-
2999. 
Gupta A (2010). Wound infiltration with local anaesthetics in ambulatory surgery. Curr Opin 
Anaesthesiol, Vol.23, No.6(dec), pp.708-13, Review, ISSN 0952-7907. 
Gurbet A, Basagan-Mogol E, Turker G, Ugun F, et al (2006). Intraoperative infusion of 
dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth, 
Vol.53, No.7(Jul), pp.646-52, ISSN 0832-610X. 
Habib A, Gan T (2005). Role of analgesic adjuncts in postoperative pain management. 
Anesthesiol Clin North America, Vol.23, No.1(Mar), pp.85-107, ISSN 0889-8537. 
Habib AS, White WD, El Gasim MA, Saleh G, et al (2008). Transdermal nicotine for analgesia 
after radical retropubic prostatectomy. Anesth Analg, Vol.107, No.3(Sep), pp.999-
1004, ISSN 0003-2999. 
Habib AS, Polascik TJ, Weizer AZ, White WD, et al (2009). Lidocaine patch for postoperative 
analgesia after radical retropubic prostatectomy. Anesth Analg, Vol.108, No.6(Jun), 
pp.1950-53, ISSN 0003-2999. 
Hartrick C, Van Hove I, Stegmann J, Oh C, et al (2009). Efficacy and tolerability of tapentadol 
immediate release and oxycodone HCl immediate release in patients awaiting 
www.intechopen.com
 
Pain Management – Current Issues and Opinions 
 
206 
primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, 
randomized, double-blind, active- and placebo-controlled study. Clin Ther, Vol.31, 
No.2(Feb), pp.260-71, ISSN 0149-2918. 
Hollmann MW, Durieux ME (2000). Local anesthetics and the inflammatory response: a new 
therapeutic indication? Anesthesiology, Vol.93, No.3(Sep), pp.858-75, ISSN 0003-
3022. 
Hurley RW, Cohen SP, Williams KA, Rowlingson AJ, et al (2006). The analgesic effects of 
perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anesth Pain 
Med, Vol.31, No.3(May-Jun), pp.237-47, ISSN 1098-7339. 
Ilfeld BM, Enneking FK (2005). Continuous peripheral nerve blocks at home: a review. 
Anesth Analg , Vol.100, No.6(Jun), pp.1822-33, Review, ISSN 0003-2999. 
Joly V, Richebe P, Guignard B, Fletcher D, et al (2005). Remifentanil-induced postoperative 
hyperalgesia and its prevention with small-dose ketamine. Anesthesiology, Vol.103, 
No.1(Jul), pp.147-55, ISSN 0003-3022. 
Jones J, Francis P (2009). Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal 
anti-inflammatory agent. Expert Opin Pharmacother, Vol.10, No.14(Oct), pp.2379-85, 
ISSN 1465-6566. 
Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, et al (2004). Effective treatment of laparoscopic 
cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. 
Anesth Analg, Vol.98, No.2(Feb), pp.336-42, ISSN 0003-2999. 
Jurna I (1995). [Antinociceptive effects of alpha(2)-adrenoceptor agonists ("analgesic" actions 
in animal experiments)agonists ("analgesic" actions in animal experiments).]. 
Schmerz, Vol.9, No.6(Nov), pp.286-92, ISSN 0932-433X. 
Kaba A, Laurent SR, Detroz BJ, Sessler DI, et al (2007). Intravenous lidocaine infusion 
facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology, Vol.106, 
No.1(Jan), pp.11-8, ISSN 0003-3022. 
Kardash KJ, Sarrazin F, Tessler MJ, Velly AM (2008). Single-dose dexamethasone reduces 
dynamic pain after total hip arthroplasty. Anesth Analg, Vol.106, No.4(Apr), 
pp.1253-57, ISSN 0003-2999. 
Karmakar MK (2001). Thoracic paravertebral block. Anesthesiology, Vol.95, No.3(Sep), 
pp.771-80, Review, ISSN 0003-3022. 
Kehlet H, Dahl JB (1993). The value of multimodal or balanced analgesia in the 
postoperative pain treatment. Anesth Analg, Vol.77, No.5(Nov), pp. 1048-56, 
Review, ISSN 0003-2999. 
Kehlet H (1997). Multimodal approach to control postoperative pathophysiology and 
rehabilitation. Br J Anaesth, Vol.78, No.5(May), pp.606-17, ISSN 0007-0912. 
Kehlet H, Werner M, Perkins F (1999). Balanced analgesia: what is it and what are its 
advantages in postoperative pain? Drugs, Vol.58, No.5(Nov), pp.793-7, ISSN 0012-
6667. 
Kehlet H, Holte K (2001). Effect of postoperative analgesia on surgical outcome. Br J Anaesth, 
Vol.87, No.1(Jul), pp.62-72, Review, ISSN 0007-0912. 
Kerr DR, Kohan L (2008). Local infiltration analgesia: a technique for the control of acute 
postoperative pain following knee and hip surgery: a case study of 325 patients. 
Acta Orthop, Vol.79, No.2(Apr), pp.174-83, ISSN 1745-3674. 
www.intechopen.com
 
Multimodal Analgesia for Postoperative Pain Management 
 
207 
Koinig H, Wallner T, Marhofer P, Andel H, et al (1998). Magnesium sulfate reduces intra- 
and postoperative analgesic requirements. Anesth Analg, Vol.87, No.1(Jul), pp.206-
10, ISSN 0003-2999. 
Lauretti GR, de Oliveira R, Reis MP, Mattos AL, et al (1999). Transdermal nitroglycerine 
enhances spinal sufentanil postoperative analgesia following orthopedic surgery. 
Anesthesiology, Vol.90, No.3(Mar), pp.734-9, ISSN 0003-3022.  
Lauretti GR, Oliveira AP, Julião MC, Reis MP, et al (2000). Transdermal nitroglycerine 
enhances spinal neostigmine postoperative analgesia following gynecological 
surgery. Anesthesiology, Vol.93, No.4(Oct), pp.943-6, ISSN 0003-3022. 
Lauwick S, Kim DJ, Michelagnoli G, Mistraletti G, et al (2008). Intraoperative infusion of 
lidocaine reduces postoperative fentanyl requirements in patients undergoing 
laparoscopic cholecystectomy. Can J Anaesth, Vol.55, No.11(Nov), pp.754-60, ISSN 
0832-610X. 
Lee A, Chan S (2006). Acupuncture and anaesthesia. Best Pract Res Clin Anaesthesiol, Vol.20, 
No.2(Jun), pp.303-14, ISSN 1521-6896. 
Legeby M, Jurell G, Beausang-Linder M, Olofsson C (2009). Placebo-controlled trial of local 
anaesthesia for treatment of pain after breast reconstruction. Scand J Plast Reconstr 
Surg Hand Surg , Vol.43, No.6, pp.315-9. ISSN 0284-4311. 
Lin TF, Yeh YC, Lin FS, Wang YP,  et al (2009). Effect of combining dexmedetomidine and 
morphine for intravenous patient-controlled analgesia. Br J Anaesth, Vol.102, 
Vol.1(Jan), pp. 117-22, ISSN 0007-0912. 
Liu SS, Salinas FV (2003). Continuous plexus and peripheral nerve blocks for postoperative 
analgesia. Anesth Analg, Vol.96, No.1(Jan), pp. 263-72, Review, ISSN 0003-2999. 
Liu SS (2004). Anesthesia and analgesia for colon surgery. Reg Anesth Pain Med, Vol.29, 
No.1(Jan-Feb), pp.52-7, ISSN 1098-7339. 
Liu SS, Wu CL (2007). Effect of postoperative analgesia on major postoperative 
complications: a systematic update of the evidence. Anesth Analg, Vol.104, 
No.3(Mar), pp.689-702, ISSN 0003-2999. 
Lysakowski C, Dumont L, Czarnetzki C, Tramer MR (2007). Magnesium as an adjuvant to 
postoperative analgesia: a systematic review of randomized trials. Anesth Analg, 
Vol.104, No.6(Jun), pp.1532-9, ISSN 0003-2999. 
Ma H, Tang J, White PF, Zaentz A, et al (2004). Perioperative rofecoxib improves early 
recovery after outpatient herniorrhaphy. Anesth Analg, Vol.98, No.4(Apr), pp.970-5, 
ISSN 0003-2999. 
Macario A, Lipman AG (2001). Ketorolac in the era of cyclo-oxygenase-2 selective 
nonsteroidal anti-inflammatory drugs: a systematic review of efficacy, side effects, 
and regulatory issues. Pain Med , Vol.2, No.4(Dec), pp.336-51, ISSN 1526-2375. 
Mathiesen O, Møiniche S, Dahl J (2007). Gabapentin and postoperative pain: a qualitative 
and quantitative systematic review, with focus on procedure. BMC Anesthesiol, 
Vol.7, No.7(Jul), pp.6, ISSN 1471-2253. 
Mathiesen O, Jacobsen L, Holm H, Randall S,  et al (2008). Pregabalin and dexamethasone 
for postoperative pain control: a randomized controlled study in hip arthroplasty. 
Br J Anaesth, Vol.101, No.4(Oct), pp.535-41, ISSN 0007-0912. 
Mathiesen O, Rasmussen ML, Dierking G, Leck H, et al (2009). Pregabalin and 
dexamethasone in combination with paracetamol for postoperative pain control 
www.intechopen.com
 
Pain Management – Current Issues and Opinions 
 
208 
after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand, 
Vol.53, No.2(Feb), pp.227-35, ISSN 0001-5172. 
McCleane G (2010). Topical application of analgesics: a clinical option in day case 
anaesthesia? Curr Opin Anaesthesiol, Vol.23, No.6(Dec), pp.704-7, ISSN 0952-7907. 
McGrath B, Elgendy H, Chung F, Kamming D, et al (2004). Thirty percent of patients have 
moderate to severe pain 24 hr after ambulatory surgery: a survey of 5,703 patients. 
Can J Anaesth, Vol.51, No.9(Nov), 886-91, ISSN 0832-610X. 
Miranda HF, Puig MM, Prieto JC, Pinardi G (2006). Synergism between paracetamol and 
nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain, Vol.121, 
No.1-2(Mar), pp.22-8, ISSN 0304-3959. 
Mitra S, Sinatra R (2004). Perioperative management of acute pain in the opioid-dependent 
patient. Anesthesiology, Vol.101, No.1(Jul), pp.212-27, ISSN 0003-3022. 
Mitra S (2008). Opioid-induced hyperalgesia: pathophysiology and clinical implications. J 
Opioid Manag, Vol.4, No.3(May-Jun), pp. 123-30, ISSN 1551-7489. 
Møiniche S, Mikkelsen S, Wetterslev J, Dahl JB (1998). A qualitative systematic review of 
incisional local anaesthesia for postoperative pain relief after abdominal operations. 
Br J Anaesth, Vol. 81, No.3(Sep), pp.377-83, ISSN 0007-0912. 
Moiniche S, Kehlet H, Dahl JB (2002). A qualitative and quantitative systematic review of 
preemptive analgesia for postoperative pain relief: the role of timing of analgesia. 
Anesthesiology, Vol.96, No.3(Mar), pp.725-41, ISSN 0003-3022. 
Ness TJ (2001). Pharmacology of peripheral analgesia. Pain Pract, Vol.1, No.3(Sep), pp.243-
54, ISSN 1530-7085.  
Nett MP (2010). Postoperative pain management. Orthopedics, Vol.33, No.9 Suppl(Sep), 
pp.23-6, ISSN 0147-7447. 
Nishimori M, Ballantyne JC, Low JH (2006). Epidural pain relief versus systemic opioid-
based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev, Vol.19, 
No.3(Jul), CD005059, ISSN 1469-493X(Electronic). 
Park JY, Lee GW, Kim Y, Yoo MJ (2002). The efficacy of continuous intrabursal infusion with 
morphine and bupivacaine for postoperative analgesia after subacromial 
arthroscopy. Reg Anesth Pain Med, Vol.27, No.2(Mar-Apr), pp.145-9, ISSN 1098-
7339. 
Perkins FM, Kehlet H (2000). Chronic pain as an outcome of surgery. A review of predictive 
factors. Anesthesiology, Vol.93, No.4(Oct), pp.1123-33; ISSN 0003-3022. 
Power I, Barratt S. Analgesic agents for the postoperative period. Nonopioids (1999). Surg 
Clin N Am, Vol.79, No.2(Apr), pp.275-95, ISSN 0039-6109. 
Practice guidelines for acute pain management in the perioperative setting: a report by the 
American Society of Anesthesiologists Task Force on Pain Management, Acute Pain 
Section (1995). Anesthesiology, Vol.82, No.4(Apr), pp.1071-81, ISSN 0003-3022. 
Pratap JN, Shankar RK, Goroszeniuk T (2007). Co-injection of clonidine prolongs the 
anesthetic effect of lidocaine skin infiltration by a peripheral action. Anesth Analg, 
Vol.104, No.4(Apr), pp.982-3, ISSN 0003-2999. 
Pusch F, Freitag H, Weinstabl C, Obwegeser R, et al (1999). Single-injection paravertebral 
block compared to general anesthesia in breast surgery. Acta Anaesthesiol Scand, 
Vol.43, No.7(Aug), pp.770-4, ISSN 0001-5172. 
Rasmussen S, Kramhøft MU, Sperling KP, Pedersen JH.(2004) Increased flexion and reduced 
hospital stay with continuous intraarticular morphine and ropivacaine after 
www.intechopen.com
 
Multimodal Analgesia for Postoperative Pain Management 
 
209 
primary total knee replacement: open intervention study of efficacy and safety in 
154 patients. Acta Orthop Scand, Vol.75, No.5(Oct), pp.606-9, ISSN 0001-6470. 
Rathmell JP, Lair TR, Nauman B (2005). The role of intrathecal drugs in the treatment of 
acute pain. Anesth Analg, Vol.101, No.5 Suppl(Nov), pp.S30-43, ISSN 0003-2999. 
Rawal N (Co-Ordinator) Postoperative Pain Management – Good Clinical Practice, General 
recommendations and principles for succesful pain management. 
http://www.esraeurope.org/PostoperativePain 
Management.pdf 
Saber AA, Elgamal AH, Rao AJ, Itawi EA, et al (2009). Early experience with lidocaine patch 
for postoperative pain control after laparoscopic ventral hernia repair. Int J Surg, 
Vol.7, No.1(Feb), pp.36-8, ISSN 1743-9191. 
Salerno A, Hermann R (2006). Efficacy and safety of steroid use for postoperative pain relief. 
Update and review of the medical literature. J Bone Joint Surg Am, Vol.88, 
No.6(June), pp.1361-72, ISSN 0021-9355. 
Schug S, Chong C (2009). Pain management after ambulatory surgery. Curr Opin 
Anaesthesiol, Vol.22, No.6(Dec), pp.738-43, ISSN 0952-7907. 
Senturk M, Ozcan PE, Talu GK, Kiyan E, et al (2002). The effects of three different analgesia 
techniques on long-term postthoracotomy pain. Anesth Analg, Vol.94, No.1(Jan), 
pp.11-5, ISSN 0003-2999. 
Sivrikaya GU, Eksioglu B, Basgul A, Enhos H, et al  (2000). The effects of preemptive 
epidural tramadol on peroperative stress response and postoperative analgesia 
(Oral communication), 19th Annual ESRA Congress, 20–23 November 2000, Rome, 
Italy. The International Monitor (IMRAPT), Vol.12, No.3, pp.65. 
Sivrikaya GU, Koc Bekil EH, Hanci A, Kilinc LT, et al (2008). The effect of combined epidural-
general anaesthesia on intraoperative stress response and postoperative analgesic 
consumption and gastrointestinal function in lower abdominal surgery. J Turk 
Anaesth Int Care, Vol.36, No.6(Nov-Dec), pp.358-65, ISSN 1304-0871.    
Sun T, Sacan O, White PF, Coleman J, et al (2008). Perioperative vs postoperative celecoxib 
on patient outcome after major plastic surgery procedures. Anesth Analg, Vol.106, 
No.3(Mar), pp.950-8, ISSN 0003-2999. 
Sun Y, Gan T, Dubose J, Habib A (2008). Acupuncture and related techniques for 
postoperative pain: a systematic review of randomized controlled trials. Br J 
AnaesthVol.101, No.2(Aug), pp.151-60, ISSN 0007-0912. 
Tiippana E, Hamunen K, Kontinen V, Kalso E (2007). Do surgical patients benefit from 
perioperative gabapentin/pregabalin? Asystematic review of efficacy and safety. 
Anesth Analg, Vol.104, No.6(Jun), pp.1545-56, ISSN 0003-2999. 
Tramer MR, Schneider J, Marti R-A, Rifat K (1996). Role of magnesium sulfate in 
postoperative analgesia. Anesthesiology , Vol.84, No.2(Feb), pp.340-7, ISSN 0003-
3022. 
Usichenko TI, Kuchling S, Witstruck T, Pavlovic D, et al (2007). Auricular acupuncture for 
pain relief after ambulatory knee surgery: a randomized trial. CMAJ, Vol.176, 
No.2(Jan), pp.179-83, ISSN 1488-2329. 
Usichenko T, Lehmann C, Ernst E (2008). Auricular acupuncture for postoperative pain 
control: a systematic review of randomised clinical trials. Anaesthesia, Vol.63, 
Vol.12(Dec), pp.1343-8, ISSN 0003-2409. 
www.intechopen.com
 
Pain Management – Current Issues and Opinions 
 
210 
Vadivelu N, Mitra S, Narayan D (2010). Recent advances in postoperative pain 
management. Yale J Biol Med, Vol.83, No.1(Mar), pp.11-25, Review, ISSN 0044-0086. 
Viscusi ER, Reynolds L, Chung F, Atkinson LE, et al (2004). Patient-controlled transdermal 
fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a 
randomized controlled trial. JAMA, Vol.17, No.11(Mar), pp.1333-41, ISSN 0098-
7484. 
Wang B, Tang J, White PF, Naruse R, et al (1997). Effect of the intensity of transcutaneous 
acupoint electrical stimulation on the postoperative analgesic requirement. Anesth 
Analg, Vol.85, No.2(Aug), pp.406-13, ISSN 0003-2999. 
Warfield CA, Kahn CH (1995). Acute pain management: programs in U.S. hospitals and 
experiences and attitudes among U.S adults. AnesthesiologyVol.83, No.5(Nov), 
pp.1090-4, ISSN 0003-3022. 
White PF, Issioui T, Skrivanek GD, Early JS, et al (2003). Use of a continuous popliteal sciatic 
nerve block for the management of pain after major podiatric surgery: does it 
improve quality of recovery? Anesth Analg, Vol.97, No.5(Nov), pp.1303-9, ISSN 
0003-2999. 
White PF (2005). The changing role of nonopioid analgesic techniques in the management of 
postoperative pain. Anesth Analg, Vol.101, No.5 Suppl(Nov), pp.S5-22, ISSN 0003-
2999. 
White PF (2007). Multimodal pain management: the future is now! Curr Opin Investig Drugs, 
Vol.8, No.7(Jul), pp.517-8, ISSN 1472-4472. 
White PF, Sacan O, Tufanogullari B, Eng M, et al (2007). Effect of short-term postoperative 
celecoxib administration on patient outcome after outpatient laparoscopic surgery. 
Can J Anaesth, Vol.54, No.5(May), pp.342-8, ISSN 0832-610X.  
White PF, Kehlet H (2007). Postoperative pain management and patient outcome: time to 
return to work! [editorial]. Anesth Analg, Vol.104, No.3(Mar), pp.487–90, ISSN 0003-
2999. 
White PF, Kehlet H, Neal JM, Schricker T, et al (2007). Role of the anesthesiologist in fast-
track surgery: from multimodal analgesia to perioperative medical care. Anesth 
Analg, Vol.104, No.6(Jun), pp.1380-96, ISSN 0003-2999. 
White PF, Kehlet H (2010). Improving postoperative pain management: what are the 
unresolved issues? Anesthesiology, Vol.112, No.1(Jan), pp.220-5, ISSN 0003-3022.  
Wu CL, Fleisher LA (2000). Outcomes research in regional anesthesia and analgesia.  Anesth 
Analg, Vol.91, No.5(Nov), pp.1232-42, ISSN 0003-2999. 
Yardeni IZ, Beilin B, Mayburd E, Levinson Y, et al (2009). The effect of perioperative 
intravenous lidocaine on postoperative pain and immune function. Anesth Analg, 
Vol.109, No.5(Nov), 1464-9, ISSN 0003-2999. 
www.intechopen.com
Pain Management - Current Issues and Opinions
Edited by Dr. Gabor Racz
ISBN 978-953-307-813-7
Hard cover, 554 pages
Publisher InTech
Published online 18, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Pain Management - Current Issues and Opinions is written by international experts who cover a number of
topics about current pain management problems, and gives the reader a glimpse into the future of pain
treatment. Several chapters report original research, while others summarize clinical information with specific
treatment options. The international mix of authors reflects the "casting of a broad net" to recruit authors on
the cutting edge of their area of interest. Pain Management - Current Issues and Opinions is a must read for
the up-to-date pain clinician.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
G. Ulufer Sivrikaya (2012). Multimodal Analgesia for Postoperative Pain Management, Pain Management -
Current Issues and Opinions, Dr. Gabor Racz (Ed.), ISBN: 978-953-307-813-7, InTech, Available from:
http://www.intechopen.com/books/pain-management-current-issues-and-opinions/multimodal-analgesia-for-
postoperative-pain-management
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
